ID	Label	"Synonyms/
Denoation"	Suggested parent term	Abbreviation	Defination	Textual Defination	Definition Source	See Also	Editor	Reviewer1	Reviewer2	Type	Parent	Close Match	Exact Match	Narrow Match	Related Match
ID	A rdfs:label			A IAO:0000605		A IAO:0000115	>A IAO:0000119	AI rdfs:seeAlso	A IAO:0000117	A IAO:0000117	A IAO:0000117	TYPE	SC %	A skos:closeMatch	A skos:exactMatch	A skos:narrowMatch	A skos:relatedMatch
pkpbo:PKPBO_00000	Physiologically Based Pharmacokinetic Modeling	PBPK Simulation	PK	PBPK	"Physiologically based pharmacokinetic (PBPK) modeling is a mathematical modeling technique that predicts the absorption, distribution, metabolism, and excretion (ADME) of synthetic or natural chemical substances in humans and other animal species"	"Physiologically based pharmacokinetic (PBPK) modeling is a mathematical modeling technique that predicts the absorption, distribution, metabolism, and excretion (ADME) of synthetic or natural chemical substances in humans and other animal species"	10.1038/psp.2013.41		0000-0001-8345-1349	0000-0002-9795-5967		Class			http://scai.fraunhofer.de/HuPSON#SCAIVPH_00000609		
pkpbo:PKPBO_00001	Whole body PBPK Model		PK	All organs PBPK	"A whole-body PBPK model contains an explicit representation of the organs that are most relevant to the absorption, distribution, excretion, and metabolization of the drug/chemicals due to their physiological/pharmacological function or their volume"	"A whole-body PBPK model contains an explicit representation of the organs that are most relevant to the absorption, distribution, excretion, and metabolization of the drug/chemicals due to their physiological/pharmacological function or their volume"	10.1002/psp4.12134		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00002	Perfusion Limited Model	Blood Flow-Limited Model/Diffusion-Limited Model	PK		"Perfusion-limited models are a type of physiologically based pharmacokinetic (PBPK) model that assumes that the concentration of a substance in tissues reaches equilibrium with the substance in the circulation rapidly. In perfusion-limited models, the rate of drug uptake by tissues is limited by blood flow, and the rate of drug elimination is limited by the rate of diffusion from the tissue to the blood"	"Perfusion-limited models are a type of physiologically based pharmacokinetic (PBPK) model that assumes that the concentration of a substance in tissues reaches equilibrium with the substance in the circulation rapidly. In perfusion-limited models, the rate of drug uptake by tissues is limited by blood flow, and the rate of drug elimination is limited by the rate of diffusion from the tissue to the blood"	"https://doi.org/10.3390/nano10071267
"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling	http://scai.fraunhofer.de/HuPSON#SCAIVPH_00000591			
pkpbo:PKPBO_00003	Physiological Parameters	Physiological variables	Physiology		"Physiological parameters in PBPK modeling provide the structural framework of the model and are used to simulate the absorption, distribution, metabolism, and excretion (ADME) of a substance throughout the body. These parameters include body weight, height, organ volume, cardiac output, organ blood flow, and tissue composition."	"Physiological parameters in PBPK modeling provide the structural framework of the model and are used to simulate the absorption, distribution, metabolism, and excretion (ADME) of a substance throughout the body. These parameters include body weight, height, organ volume, cardiac output, organ blood flow, and tissue composition."	10.3390/ijerph20043473		0000-0001-8345-1349	0000-0002-9795-5967		Class	Perfusion Limited Model		http://scai.fraunhofer.de/HuPSON#SCAIVPH_00000457		
pkpbo:PKPBO_00004	 Body Mass Index 	"Body Mass Index
Quetelet Index
body mass index
BMI"	Physicochemical Parameter	BMI	"A general indicator of the body fat an individual is carrying based upon the ratio of weight to height.
A measure that relates body weight to height. BMI is sometimes used to measure total body fat and whether a person is a healthy weight."	An individual's weight in kilograms divided by the square of the height in meters.	http://purl.obolibrary.org/obo/NCIT_C16358		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters		http://purl.bioontology.org/ontology/MESH/D015992		
pkpbo:PKPBO_00005	Body weight	"Weights, Body"	Physicochemical Parameter	BW	The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.	 Mass or quantity of heaviness of an individual. 	http://purl.bioontology.org/ontology/MESH/D001835		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters		http://purl.bioontology.org/ontology/MESH/D001835		
pkpbo:PKPBO_00006	Body Height	human height	Physicochemical Parameter	HT	Height is a term used to describe the distance from the bottom to the top of someone or something standing upright	Height is a term used to describe the distance from the bottom to the top of someone or something standing upright	Height Definition & Meaning - Merriam-Webster		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters		http://purl.bioontology.org/ontology/MESH/D001827		
pkpbo:PKPBO_00007	Body surface area	"Body surface area/Areas, Body Surface"	Physicochemical Parameter	BSA/SA	The surface area of a is a measure of the total area that the surface of the object occupies.	" A measure of  total area i.e., surface of  object occupies. or
 
The two dimensional measure of the outer layer of the body."	"http://semanticscience.org/resource/SIO_001407

http://purl.bioontology.org/ontology/MESH/D001830"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters		http://purl.bioontology.org/ontology/MESH/D001830		
pkpbo:PKPBO_00008	Race	"RACE
Racial Group
Patient Reported Race"	Physicochemical Parameter		"An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution."	A geographic ancestral origin category  assigned to a population group .	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17049		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters		http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17049		
pkpbo:PKPBO_00009	Blood flow	blood perfusion	CVS	Q	"Blood flow in PBPK modeling refers to the rate of blood flow to a particular organ or tissue, which is used to calculate the rate of drug/chemical delivery to that organ or tissue"	"Blood flow in PBPK modeling refers to the rate of blood flow to a particular organ or tissue, which is used to calculate the rate of drug delivery to that organ or tissue/chemical"	10.1002/psp4.12134		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters		http://purl.org/obo/owl/GO#GO_0008015		
pkpbo:PKPBO_00010	Cardiac Output	Stroke volume	CVS	CO	"Cardiac output in PBPK modeling refers to the volume of blood pumped by the heart per unit of time, which is used to calculate the rate of blood flow to different organs and tissues in the body"	"Cardiac output in PBPK modeling refers to the volume of blood pumped by the heart per unit of time, which is used to calculate the rate of blood flow to different organs and tissues in the body"	10.3390/ijerph20043473		0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow		http://purl.bioontology.org/ontology/MESH/D002302		
pkpbo:PKPBO_00011	Qstomach		Blood flow 		"Qstomach is a parameter used in PBPK modeling to describe the blood flow rate to the stomach, which is used to calculate the rate of drug/chemical delivery to the stomach. The value of Qstomach depends on the species of interest and is defined by the stomach weight/volume and cardiac output"	"Qstomach is a parameter used in PBPK modeling to describe the blood flow rate to the stomach, which is used to calculate the rate of drug/chemical delivery to the stomach. The value of Qstomach depends on the species of interest and is defined by the stomach weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00012	FQstomach		Blood flow		Fraction of blood flow to stomach	Fraction of blood flow to stomach	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qstomach				
pkpbo:PKPBO_00013	Qintestine		Blood flow 		"Qintestine is a parameter used in PBPK modeling to describe the blood flow rate to the intestine, which is used to calculate the rate of drug/chemical delivery to the intestine. The value of Qintestine depends on the species of interest and is defined by the intestine weight/volume and cardiac output"	"Qintestine is a parameter used in PBPK modeling to describe the blood flow rate to the intestine, which is used to calculate the rate of drug/chemical delivery to the intestine. The value of Qintestine depends on the species of interest and is defined by the intestine weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00014	FQintestine		Blood flow 		Fraction of blood flow to intestine	Fraction of blood flow to intestine	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qintestine				
pkpbo:PKPBO_00015	Qsmall intestine		Blood flow 		"Qsmall intestine is a parameter used in PBPK modeling to describe the blood flow rate to the small intestine, which is used to calculate the rate of drug/chemical delivery to the small intestine. The value of Qsmall intestine depends on the species of interest and is defined by the small intestine weight/volume and cardiac output"	"Qsmall intestine is a parameter used in PBPK modeling to describe the blood flow rate to the small intestine, which is used to calculate the rate of drug/chemical delivery to the small intestine. The value of Qsmall intestine depends on the species of interest and is defined by the small intestine weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00016	FQsmall intestine		Blood flow 		Fraction of blood flow to small intestine	Fraction of blood flow to small intestine	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qsmall intestine				
pkpbo:PKPBO_00017	Qlarge intestine		Blood flow 		"Qlarge intestine is a parameter used in PBPK modeling to describe the blood flow rate to the large intestine, which is used to calculate the rate of drug/chemical delivery to the large intestine. The value of Qlarge intestine depends on the species of interest and is defined by the large intestine weight/volume and cardiac output"	"Qlarge intestine is a parameter used in PBPK modeling to describe the blood flow rate to the large intestine, which is used to calculate the rate of drug/chemical delivery to the large intestine. The value of Qlarge intestine depends on the species of interest and is defined by the large intestine weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00018	FQlarge intestine		Blood flow 		Fraction of blood flow to large intestine	Fraction of blood flow to large intestine	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qlarge intestine				
pkpbo:PKPBO_00019	Qpancreas		Blood flow 		"Qpancreas is a parameter used in PBPK modeling to describe the blood flow rate to the pancreas, which is used to calculate the rate of drug/chemical delivery to the pancreas. The value of Qpancreas depends on the species of interest and is defined by the pancreas weight/volume and cardiac output"	"Qpancreas is a parameter used in PBPK modeling to describe the blood flow rate to the pancreas, which is used to calculate the rate of drug/chemical delivery to the pancreas. The value of Qpancreas depends on the species of interest and is defined by the pancreas weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00020	FQpancreas		Blood flow 		Fraction of blood flow to pancreas	Fraction of blood flow to pancreas	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qpancreas				
pkpbo:PKPBO_00021	Qliver		Blood flow 		"Qliver is a parameter used in PBPK modeling to describe the blood flow rate to the liver, which is used to calculate the rate of drug/chemical delivery to the liver. The value of Qliver depends on the species of interest and is defined by the liver weight/volume and cardiac output"	"Qliver is a parameter used in PBPK modeling to describe the blood flow rate to the liver, which is used to calculate the rate of drug/chemical delivery to the liver. The value of Qliver depends on the species of interest and is defined by the liver weight/volume and cardiac output"	"10.1002/psp4.12134
https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-reporting-physiologically-based-pharmacokinetic-pbpk-modelling-simulation_en.pdf"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00022	FQliver	FQhepatic	Blood flow 		Fraction of blood flow to liver	Fraction of blood flow to liver	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qliver				
pkpbo:PKPBO_00023	Qkidney		Blood flow 		"Qkidney is a parameter used in PBPK modeling to describe the blood flow rate to the kidney, which is used to calculate the rate of drug/chemical delivery to the kidney. The value of Qkidney depends on the species of interest and is defined by the kidney weight/volume and cardiac output"	"Qkidney is a parameter used in PBPK modeling to describe the blood flow rate to the kidney, which is used to calculate the rate of drug/chemical delivery to the kidney. The value of Qkidney depends on the species of interest and is defined by the kidney weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00024	FQkidney	FQrenal	Blood flow 		Fraction of blood flow to kidney	Fraction of blood flow to kidney	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qkidney				
pkpbo:PKPBO_00025	Qmuscle		Blood flow 		"Qmuscle is a parameter used in PBPK modeling to describe the blood flow rate to the muscle, which is used to calculate the rate of drug/chemical delivery to the muscle. The value of Qmuscle depends on the species of interest and is defined by the muscle weight/volume and cardiac output"	"Qmuscle is a parameter used in PBPK modeling to describe the blood flow rate to the muscle, which is used to calculate the rate of drug/chemical delivery to the muscle. The value of Qmuscle depends on the species of interest and is defined by the muscle weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00026	FQmuscle		Blood flow 		Fraction of blood flow to muscle	Fraction of blood flow to muscle	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qmuscle				
pkpbo:PKPBO_00027	Qheart		Blood flow 		"Qheart is a parameter used in PBPK modeling to describe the blood flow rate to the heart, which is used to calculate the rate of drug/chemical delivery to the heart. The value of Qheart depends on the species of interest and is defined by the heart weight/volume and cardiac output"	"Qheart is a parameter used in PBPK modeling to describe the blood flow rate to the heart, which is used to calculate the rate of drug/chemical delivery to the heart. The value of Qheart depends on the species of interest and is defined by the heart weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00028	FQheart	FQcardiac	Blood flow 		Fraction of blood flow to heart	Fraction of blood flow to heart	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qheart				
pkpbo:PKPBO_00029	Qfat		Blood flow 	Qadipose tissue	"Qfat is a parameter used in PBPK modeling to describe the blood flow rate to the fat, which is used to calculate the rate of drug/chemical delivery to the fat. The value of Qfat depends on the species of interest and is defined by the fat weight/volume and cardiac output"	"Qfat is a parameter used in PBPK modeling to describe the blood flow rate to the fat, which is used to calculate the rate of drug/chemical delivery to the fat. The value of Qfat depends on the species of interest and is defined by the fat weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00030	FQfat		Blood flow 		Fraction of blood flow to fat	Fraction of blood flow to fat	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qfat				
pkpbo:PKPBO_00031	Qgonads		Blood flow 		"Qgonads is a parameter used in PBPK modeling to describe the blood flow rate to the gonads, which is used to calculate the rate of drug/chemical delivery to the gonads. The value of Qgonads depends on the species of interest and is defined by the gonads weight/volume and cardiac output"	"Qgonads is a parameter used in PBPK modeling to describe the blood flow rate to the gonads, which is used to calculate the rate of drug/chemical delivery to the gonads. The value of Qgonads depends on the species of interest and is defined by the gonads weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00032	FQgonads		Blood flow 		Fraction of blood flow to gonads	Fraction of blood flow to gonads	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qgonads				
pkpbo:PKPBO_00033	Qskin		Blood flow 		"Qskin is a parameter used in PBPK modeling to describe the blood flow rate to the skin, which is used to calculate the rate of drug/chemical delivery to the skin. The value of Qskin depends on the species of interest and is defined by the skin weight/volume and cardiac output"	"Qskin is a parameter used in PBPK modeling to describe the blood flow rate to the skin, which is used to calculate the rate of drug/chemical delivery to the skin. The value of Qskin depends on the species of interest and is defined by the skin weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00034	FQskin		Blood flow 		Fraction of blood flow to skin	Fraction of blood flow to skin	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qskin				
pkpbo:PKPBO_00035	Qbone		Blood flow 		"Qbone is a parameter used in PBPK modeling to describe the blood flow rate to the bone, which is used to calculate the rate of drug/chemical delivery to the bone. The value of Qbone depends on the species of interest and is defined by the bone weight/volume and cardiac output"	"Qbone is a parameter used in PBPK modeling to describe the blood flow rate to the bone, which is used to calculate the rate of drug/chemical delivery to the bone. The value of Qbone depends on the species of interest and is defined by the bone weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00036	FQbone		Blood flow 		Fraction of blood flow to bone	Fraction of blood flow to bone	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qbone				
pkpbo:PKPBO_00037	Qbrain		Blood flow 		"Qbrain is a parameter used in PBPK modeling to describe the blood flow rate to the brain, which is used to calculate the rate of drug/chemical delivery to the brain. The value of Qbrain depends on the species of interest and is defined by the brain weight/volume and cardiac output"	"Qbrain is a parameter used in PBPK modeling to describe the blood flow rate to the brain, which is used to calculate the rate of drug/chemical delivery to the brain. The value of Qbrain depends on the species of interest and is defined by the brain weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00038	FQbrain		Blood flow 		Fraction of blood flow to brain	Fraction of blood flow to brain	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qbrain				
pkpbo:PKPBO_00039	Qspleen		Blood flow 		"Qspleen is a parameter used in PBPK modeling to describe the blood flow rate to the spleen, which is used to calculate the rate of drug/chemical delivery to the spleen. The value of Qspleen depends on the species of interest and is defined by the spleen weight/volume and cardiac output"	"Qspleen is a parameter used in PBPK modeling to describe the blood flow rate to the spleen, which is used to calculate the rate of drug/chemical delivery to the spleen. The value of Qspleen depends on the species of interest and is defined by the spleen weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00040	FQspleen		Blood flow 		Fraction of blood flow to spleen	Fraction of blood flow to spleen	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qspleen				
pkpbo:PKPBO_00041	Qlung		Blood flow 		"Qlung is a parameter used in PBPK modeling to describe the blood flow rate to the lung, which is used to calculate the rate of drug/chemical delivery to the lung. The value of Qlung depends on the species of interest and is defined by the lung weight/volume and cardiac output"	"Qlung is a parameter used in PBPK modeling to describe the blood flow rate to the lung, which is used to calculate the rate of drug/chemical delivery to the lung. The value of Qlung depends on the species of interest and is defined by the lung weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00042	FQlung		Blood flow 		Fraction of blood flow to lung	Fraction of blood flow to lung	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qlung				
pkpbo:PKPBO_00043	Qpoorly perfused		Blood flow 		"Qpoorly perfused is a parameter used in PBPK modeling to describe the blood flow rate to the poorly perfused organ/tissue, which is used to calculate the rate of drug/chemical delivery to the poorly perfused organ/tissue. The value of Qpoorly perfused depends on the species of interest and is defined by the poorly perfused organ/tissue weight/volume and cardiac output"	"Qpoorly perfused is a parameter used in PBPK modeling to describe the blood flow rate to the poorly perfused organ/tissue, which is used to calculate the rate of drug/chemical delivery to the poorly perfused organ/tissue. The value of Qpoorly perfused depends on the species of interest and is defined by the poorly perfused organ/tissue weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00044	FQpoorly perfused		Blood flow 		Fraction of blood flow to poorly perfused tissues/organ	Fraction of blood flow to poorly perfused tissues/organ	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qpoorly perfused				
pkpbo:PKPBO_00045	Qrichly perfused		Blood flow 		"Qrichly perfused is a parameter used in PBPK modeling to describe the blood flow rate to the richly perfused organ/tissue, which is used to calculate the rate of drug/chemical delivery to the richly perfused organ/tissue. The value of Qrichly perfused depends on the species of interest and is defined by the richly perfused organ/tissue weight/volume and cardiac output"	"Qrichly perfused is a parameter used in PBPK modeling to describe the blood flow rate to the richly perfused organ/tissue, which is used to calculate the rate of drug/chemical delivery to the richly perfused organ/tissue. The value of Qrichly perfused depends on the species of interest and is defined by the richly perfused organ/tissue weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00046	FQrichly perfused		Blood flow 		Fraction of blood flow to richly perfused tissues/organs	Fraction of blood flow to richly perfused tissues/organs	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Qrichly perfused				
pkpbo:PKPBO_00047	Qrestbody		Blood flow 		"Qrestbody is a parameter used in PBPK modeling to describe the blood flow rate to the remaining organ/tissue, which is used to calculate the rate of drug/chemical delivery to the remaining organ/tissue. The value of Qrestbody can be obtained by subtracting the total body blood flow with the blood flow of each organs/tissue present in the model."	"Qrestbody is a parameter used in PBPK modeling to describe the blood flow rate to the remaining organ/tissue, which is used to calculate the rate of drug/chemical delivery to the remaining organ/tissue. The value of Qrestbody can be obtained by subtracting the total body blood flow with the blood flow of each organs/tissue present in the model."			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00048	FQrestbody											Class	Qrestbody				
pkpbo:PKPBO_00049	Qgallballder		Blood flow 		"Qgall bladder is a parameter used in PBPK modeling to describe the blood flow rate to the gall bladder, which is used to calculate the rate of drug/chemical delivery to the gall bladder. The value of Qgall bladder depends on the species of interest and is defined by the gall bladder weight/volume and cardiac output"	"Qgall bladder is a parameter used in PBPK modeling to describe the blood flow rate to the gall bladder, which is used to calculate the rate of drug/chemical delivery to the gall bladder. The value of Qgall bladder depends on the species of interest and is defined by the gall bladder weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00050	FQgallballder											Class	Qgallballder				
pkpbo:PKPBO_00051	Qportal vein		Blood flow 		"Qportal vein is a parameter used in PBPK modeling to describe the blood flow rate to the portal vein, which is used to calculate the rate of drug/chemical delivery to the portal vein. The value of Qportal vein depends on the species of interest and is defined by the portal vein weight/volume and cardiac output"	"Qportal vein is a parameter used in PBPK modeling to describe the blood flow rate to the portal vein, which is used to calculate the rate of drug/chemical delivery to the stomach. The value of Qportal vein depends on the species of interest and is defined by the portal vein weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00052	FQportal vein											Class	Qportal vein				
pkpbo:PKPBO_00053	Qlymph		Blood flow 		"Qlymph is a parameter used in PBPK modeling to describe the blood flow rate to the lymph, which is used to calculate the rate of drug/chemical delivery to the lymph. The value of Qlymph depends on the species of interest and is defined by the lymph weight/volume and cardiac output"	"Qlymph is a parameter used in PBPK modeling to describe the blood flow rate to the lymph, which is used to calculate the rate of drug/chemical delivery to the lymph. The value of Qlymph depends on the species of interest and is defined by the lymph weight/volume and cardiac output"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow				
pkpbo:PKPBO_00054	FQlymph											Class	Qlymph				
pkpbo:PKPBO_00055	Arterial blood flow		Blood flow 		Arterial blood flow in PBPK modeling represents the rate of blood flow to the tissues and organs through the arterial system. This parameter is essential for estimating the distribution of drugs and other substances in the body	Arterial blood flow in PBPK modeling represents the rate of blood flow to the tissues and organs through the arterial system. This parameter is essential for estimating the distribution of drugs and other substances in the body	"10.1007/s40268-020-00325-0
10.1186/1472-6904-4-2"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow		http://purl.obolibrary.org/obo/CMO_0000198		
pkpbo:PKPBO_00056	Venous blood flow		Blood flow 		Venous blood flow in PBPK modeling represents the rate of blood flow returning from the tissues and organs through the venous system. This parameter is essential for estimating the distribution of drugs/chemicals and other substances in the body.	Venous blood flow in PBPK modeling represents the rate of blood flow returning from the tissues and organs through the venous system. This parameter is essential for estimating the distribution of drugs/chemicals and other substances in the body.			0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow		http://purl.obolibrary.org/obo/CMO_0000199		
pkpbo:PKPBO_00057	Glomerular filtration rate		Blood flow 	GFR	Glomerular filtration rate (GFR) is a measure of kidney function that describes the flow rate of filtered fluid through the kidney	Glomerular filtration rate (GFR) is a measure of kidney function that describes the flow rate of filtered fluid through the kidney	Glomerular filtration rate - Wikipedia		0000-0001-8345-1349	0000-0002-9795-5967		Class	Blood flow		http://purl.bioontology.org/ontology/MESH/D005919		
pkpbo:PKPBO_00058	Volume of organ		Volume of organ	Vorgan	Organ volume in PBPK modeling refers to the volume of a specific organ or tissue in the body. 	Organ volume in PBPK modeling refers to the volume of a specific organ or tissue in the body. 	10.1002/psp4.12205		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters				
pkpbo:PKPBO_00059	Vstomach		Volume of organ		Volume of stomach	Volume of stomach	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00060	Fstomach		Volume of organ		stomach volume as a fraction of total body weight	stomach volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vstomach				
pkpbo:PKPBO_00061	Vintestine		Volume of organ		Volume of intestine	Volume of intestine	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00062	Fintestine		Volume of organ		intestine volume as a fraction of total body weight	intestine volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vintestine				
pkpbo:PKPBO_00063	Vsmall intestine		Volume of organ		Volume of small intestine	Volume of small intestine	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00064	Fsmall intestine		Volume of organ		small intestine volume as a fraction of total body weight	small intestine volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vsmall intestine				
pkpbo:PKPBO_00065	Vlarge intestine		Volume of organ		Volume of large intestine	Volume of large intestine	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00066	Flarge intestine		Volume of organ		large intestine volume as a fraction of total body weight	large intestine volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vlarge intestine				
pkpbo:PKPBO_00067	Vpancreas		Volume of organ		Volume of pancreas	Volume of pancreas	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00068	Fpancreas		Volume of organ		pancreas volume as a fraction of total body weight	pancreas volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vpancreas				
pkpbo:PKPBO_00069	Vliver		Volume of organ		Volume of liver	Volume of liver	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00070	Fliver		Volume of organ		liver volume as a fraction of total body weight	liver volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vliver				
pkpbo:PKPBO_00071	Vkidney		Volume of organ		Volume of kidney	Volume of kidney	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00072	Fkidney		Volume of organ		kidney volume as a fraction of total body weight	kidney volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vkidney				
pkpbo:PKPBO_00073	Vmuscle		Volume of organ		Volume of muscle	Volume of muscle	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00074	Fmuscle		Volume of organ		muscle volume as a fraction of total body weight	muscle volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vmuscle				
pkpbo:PKPBO_00075	Vheart		Volume of organ		Volume of heart	Volume of heart	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00076	Fheart		Volume of organ		heart volume as a fraction of total body weight	heart volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vheart				
pkpbo:PKPBO_00077	Vfat		Volume of organ		Volume of fat	Volume of fat	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00078	Ffat		Volume of organ		fat volume as a fraction of total body weight	fat volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vfat				
pkpbo:PKPBO_00079	Vgonads		Volume of organ		Volume of gonads	Volume of gonads	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00080	Fgonads		Volume of organ		gonads volume as a fraction of total body weight	gonads volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vgonads				
pkpbo:PKPBO_00081	Vskin		Volume of organ		Volume of skin	Volume of skin	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00082	Fskin		Volume of organ		skin volume as a fraction of total body weight	skin volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vskin				
pkpbo:PKPBO_00083	Vbone		Volume of organ		Volume of bone	Volume of bone	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00084	Fbone		Volume of organ		bone volume as a fraction of total body weight	bone volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vbone				
pkpbo:PKPBO_00085	Vbrain		Volume of organ		Volume of brain	Volume of brain	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00086	Fbrain		Volume of organ		brain volume as a fraction of total body weight	brain volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vbrain				
pkpbo:PKPBO_00087	Vspleen		Volume of organ		Volume of spleen	Volume of spleen	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00088	Fspleen		Volume of organ		spleen volume as a fraction of total body weight	spleen volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vspleen				
pkpbo:PKPBO_00089	Vlung		Volume of organ		Volume of lung	Volume of lung	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00090	Flung		Volume of organ		lung volume as a fraction of total body weight	lung volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vlung				
pkpbo:PKPBO_00091	Vpoorly perfused		Volume of organ		Volume of poorly perfused tissue/organ	Volume of poorly perfused tissue/organ	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00092	Fpoorly perfused		Volume of organ		poorly perfused tissues/organs volume as a fraction of total body weight	poorly perfused tissues/organs volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vpoorly perfused				
pkpbo:PKPBO_00093	Vrichly perfused		Volume of organ		Volume of richly perfused tissue/organ	Volume of richly perfused tissue/organ	https://doi.org/10.1016/j.envres.2022.114074		0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00094	Frichly perfused		Volume of organ		richly perfused tissues/organs volume as a fraction of total body weight	richly perfused tissues/organs volume as total body weight fraction	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Vrichly perfused				
pkpbo:PKPBO_00095	Vplasma		Volume of organ		Volume of the plasma	Volume of the plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00096	Fplasma											Class	Vplasma				
pkpbo:PKPBO_00097	Vrestbody		Volume of organ		Volume of the restbody	Volume of the restbody			0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00098	Frestbody											Class	Vrestbody				
pkpbo:PKPBO_00099	vgallbaldder		Volume of organ		Volume of the gallbaldder 	Volume of the gallbaldder 			0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00100	Fgallbladder											Class	vgallbaldder				
pkpbo:PKPBO_00101	vportal vein		Volume of organ		Volume of the portal vein	Volume of the portal vein			0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00102	Fportal vein											Class	vportal vein				
pkpbo:PKPBO_00103	vlymph		Volume of organ		Volume of the lymph	Volume of the lymph			0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ				
pkpbo:PKPBO_00104	Flymph											Class	vlymph				
pkpbo:PKPBO_00105	Arterial volume		Volume of organ		Volume of the Arteries	Volume of the Arteries			0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ	http://purl.bioontology.org/ontology/LNC/LP430862-5			
pkpbo:PKPBO_00106	venous volume		Volume of organ		Volume of the veins	Volume of the veins			0000-0001-8345-1349	0000-0002-9795-5967		Class	Volume of organ		http://purl.bioontology.org/ontology/LNC/MTHU068040		
pkpbo:PKPBO_00107	Sex	Genotypic	Gender		"The totality of characteristics of reproductive structure, functions, PHENOTYPE, and GENOTYPE, differentiating the MALE from the FEMALE organism"	"Characteristics totality of reproductive structure, functions, PHENOTYPE, GENOTYPE to differentiate MALE from  FEMALE organism"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters		http://purl.bioontology.org/ontology/MESH/D012723		
pkpbo:PKPBO_00108	Male	Masculine	Gender	M	"Biologically, males are defined as the sex that produces the smaller gametes s (e.g. sperm )"	"Males, as sex i,e. produces smaller gametes (e.g. sperm)"	https://sci-hub.se/https://doi.org/10.1093/molehr/gau068		0000-0001-8345-1349	0000-0002-9795-5967		Class	Sex		http://purl.bioontology.org/ontology/MESH/D008297		
pkpbo:PKPBO_00109	Female	Feminine	Gender	F	"Biologically, Females are defined as the sex that exist in species with gamete dimorphism (anisogamy)."	"Females, as sex i,e. produces gamete dimorphism (anisogamy)"	https://sci-hub.se/https://doi.org/10.1093/molehr/gau069		0000-0001-8345-1349	0000-0002-9795-5967		Class	Sex		http://purl.bioontology.org/ontology/MESH/D005260		
pkpbo:PKPBO_00110	Physicochemical Parameters				"Physicochemical parameters of a compound include molecular weight (MW), lipophilicity, solubility, and pKa values, which can usually be determined in vitro. The physicochemical properties of a compound are used to parameterize the PBPK model"	"Physicochemical parameters of a compound include molecular weight (MW), lipophilicity, solubility, and pKa values, which can usually be determined in vitro. The physicochemical properties of a compound are used to parameterize the PBPK model"	"10.3390/ijerph20043473
https://cot.food.gov.uk/sites/default/files/2021-01/TOX-2019-34%20PBPK%20used%20for%20human%20health%20risk%20assessment.pdf
"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00112	Molecular weight	"Weights, Molecular"	Physicochemical Parameter	MW	The sum of the weight of all the atoms in a molecule.	Sum of weight of all the atoms in a molecule.	http://purl.bioontology.org/ontology/MESH/D008970		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters		http://purl.bioontology.org/ontology/MESH/D008970		
pkpbo:PKPBO_00113	Lipophillicity		Physicochemical Parameter		Lipophilicity defined as the affinity or tendency of a substance to dissolve in lipids or hydrophobic environments.	" Affinity of a molecule or a moiety
for a lipophilic environment "	https://sci-hub.se/10.1016/j.microc.2019.01.030		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters				
pkpbo:PKPBO_00114	Distribution coefficients		Physicochemical Parameter	Log D	LogD is the ratio of equilibrium concentration of compound in an organic phase to total concentation of un-ionized and ionized species in the aqueous phase at a given pH.	"LogD distribution constant, better descriptor of lipophilicity of a molecule."	"https://doi.org/10.3109/00498258809041669
https://pubs.acs.org/doi/abs/10.1021/jm00211a010"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters				
pkpbo:PKPBO_00115	Log P	Partition Coefficient 	Physicochemical Parameter		LogP is defined as the partition coefficient of a molecule between aqueous and lipophilic phases usually considered as octanol and water.	 Ratio of a dissolved xenoboitic substance in a two-phase system. 	"https://doi.org/10.3109/00498258809041669
https://pubs.acs.org/doi/abs/10.1021/jm00211a010
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20610"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20610			
pkpbo:PKPBO_00116	Log S	Intrinsic solubility	Physicochemical Parameter		LogS is directly related to the water solubility of a Xenobiotic defined as a common solubility unit corresponding to the 10-based logarithm of the solubility of a molecule measured in mol/L. 	"Xenoboitic Solubility unit corresponding to  10-based logarithm measured in mol/L. or
log (solubility measured in mol/l)."	"https://dev.Xenoboiticbank.com/guides/terms/log-s
https://docs.chemaxon.com/display/docs/theory-of-aqueous-solubility-prediction.md"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters	http://purl.bioontology.org/ontology/MESH/D012995			
pkpbo:PKPBO_00117	Water solubility		Physicochemical Parameter						0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters				
pkpbo:PKPBO_00118	pka (strongest acidic)	Acid dissociation constant	Physicochemical Parameter	pka	"The pKa is the negative base-10 logarithm of the acid dissociation constant (Ka) of a solution. The lower the pKa, the stronger the acid. "	Negative base-10 logarithm of acid dissociation constant (Ka) of a solution	"http://semanticscience.org/resource/CHEMINF_000195
https://dev.Xenoboiticbank.com/guides/terms/pka"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters		http://www.bioassayontology.org/bao#BAO_0002131		
pkpbo:PKPBO_00119	pkb (strongest basic)	base dissociation constant	Physicochemical Parameter	"pKb pK(b) pK(B) affinity constant, Base dissociation constan"	"The strength of a base is determined by using pKb.
The pKb is the negative base-10 logarithm of the base dissociation constant (Kb) of a solution. The lower the pKb, the stronger the base."	Negative base-10 logarithm of base dissociation constant (Ka) of a solution	"https://uts.nlm.nih.gov/uts.html
http://www.semanticweb.org/ontologies/2010/3/Ontology1271664172453.owl#pKb"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters		http://www.bioassayontology.org/bao#BAO_0190006		
pkpbo:PKPBO_00120	physiological charge		Physicochemical Parameter						0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters				
pkpbo:PKPBO_00121	Hydrogen acceptor count	Acceptor	Physicochemical Parameter	A	"A descriptor that reflects the integer number of hydrogen bond acceptors in a given molecular entity, as determined by a given method. In highly simplified terms, this is usually the count of all negatively or partially negatively charged heteroatoms (e.g. alcohol oxygen) capable of accepting a hydrogen bond."	A descriptor reflects  integer number of hydrogen bond acceptors in a given molecular entity.	"
http://purl.obolibrary.org/obo/CHEBI_13193
http://semanticscience.org/resource/CHEMINF_000245"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters	http://purl.obolibrary.org/obo/CHEBI_13193			
pkpbo:PKPBO_00122	Hydrogen donor count	"Donor
Reduced acceptor
AH2
Hydrogen-donor"	Physicochemical Parameter		" 
A molecular entity that can undergo oxidation by the loss of hydrogen atom(s)."	" 
A molecule can undergo oxidation by  loss of hydrogen."	"
http://purl.obolibrary.org/obo/CHEBI_17499"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters	http://purl.obolibrary.org/obo/CHEBI_17499			
pkpbo:PKPBO_00123	rotable bond count	bond count	Physicochemical Parameter		A descriptor that specifies the integer count of bonds in a given molecular entity	An integer count of bonds in a given molecular entity	http://semanticscience.org/resource/CHEMINF_000233		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physicochemical Parameters				
pkpbo:PKPBO_00124	Biochemical Parameters											Class	Perfusion Limited Model				
pkpbo:PKPBO_00125	Absorption		PK	A	Drug/chemical absorption is a pharmacokinetic parameter that refers to the way a drug/chemical is absorbed from a particular source (e.g. formulation) into the bloodstream.	Drug/chemical absorption is a pharmacokinetic parameter that refers to the way a drug/chemical is absorbed from a particular source (e.g. formulation) into the bloodstream	"https://www.news-medical.net/health/What-is-Drug-Absorption.aspx
https://www.ncbi.nlm.nih.gov/books/NBK557744/"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biochemical Parameters	http://vocabs.lter-europe.net/EnvThes/21448	http://purl.bioontology.org/ontology/MESH/D000042		
pkpbo:PKPBO_00126	Absorption rate constant gut		PK	Kagut	"The absorption rate constant (kabs) is used in the PBPK model to define absorption, which is the movement of a xenobiotic from its site of delivery (gut) to systemic circulation or another compartment"	"The absorption rate constant (kabs) is used in the PBPK model to define absorption, which is the movement of a xenobiotic from its site of delivery (gut) to systemic circulation or another compartment"	10.3390/ijerph20043473		0000-0001-8345-1349	0000-0002-9795-5967		Class	Absorption				
pkpbo:PKPBO_00127	Absorption rate constant intestine	Intestine Absorption coefficient	PK	Kaintestine	"The absorption rate constant (kabs) is used in the PBPK model to define absorption, which is the movement of a xenobiotic from its site of delivery (intestine) to systemic circulation or another compartment"	"The absorption rate constant (kabs) is used in the PBPK model to define absorption, which is the movement of a xenobiotic from its site of delivery (intestine) to systemic circulation or another compartment"	10.3390/ijerph20043473		0000-0001-8345-1349	0000-0002-9795-5967		Class	Absorption				
pkpbo:PKPBO_00128	Gastric emptying	"Gastric depletion/
Gastric Emptyings"	GIT motility	GE	Gastric emptying in PBPK refers to the rate at which the stomach empties its contents into the small intestine. It is an important parameter in PBPK modeling as it can affect the absorption of drugs and xenobiotics.	Gastric emptying in PBPK refers to the rate at which the stomach empties its contents into the small intestine. It is an important parameter in PBPK modeling as it can affect the absorption of drugs and xenobiotics.	10.1007/s10928-007-9073-1		0000-0001-8345-1349	0000-0002-9795-5967		Class	Absorption		http://purl.bioontology.org/ontology/MESH/D005746		
pkpbo:PKPBO_00129	Enterohepatic recirculation	"Circulations,
 Entero-Hepatic"	Metabolism	EHR	"Recycling through liver by excretion in bile, reabsorption from intestines (INTESTINAL REABSORPTION) into portal circulation, passage back into liver, and re-excretion in bile."	"Recycling through liver by excretion in bile, reabsorption from intestines into portal circulation, passage back into liver, and re-excretion in bile"	http://purl.bioontology.org/ontology/MESH/D004764		0000-0001-8345-1349	0000-0002-9795-5967		Class	Absorption	http://purl.bioontology.org/ontology/MESH/D004764			
pkpbo:PKPBO_00130	Specific Intestinal Permeability	" 
gut permeability measurement"	Intestinal Permeability		Specific intestinal permeability in PBPK refers to the surface area-normalized transcellular permeability of the intestinal wall for a specific drug or xenobiotic. It is an important parameter in PBPK modeling as it can affect the absorption of drugs and xenobiotics in the intestine	Specific intestinal permeability in PBPK refers to the surface area-normalized transcellular permeability of the intestinal wall for a specific drug or xenobiotic. It is an important parameter in PBPK modeling as it can affect the absorption of drugs and xenobiotics in the intestine	10.3390/pharmaceutics11080411		0000-0001-8345-1349	0000-0002-9795-5967		Class	Absorption				http://purl.jp/bio/4/id/201106061280498045
pkpbo:PKPBO_00131	Distribution				Process of drug/chemical movement from systemic circulation to various organs/tissues of the body	Process of drug/chemical movement from systemic circulation to various organs/tissues of the body	10.1038/psp.2013.41		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biochemical Parameters				
pkpbo:PKPBO_00132	Volume of distribution	Aparent volume of distribution	Distribution	Vd	"It refers to the apparent volume in which a drug/chemical is distributed in the body, taking into account the concentration of the drug/chemical in plasma and tissues"	"It refers to the apparent volume in which a drug/chemical is distributed in the body, taking into account the concentration of the drug/chemical in plasma and tissues"	10.12793/tcp.2020.28.e19		0000-0001-8345-1349	0000-0002-9795-5967		Class	Distribution				
pkpbo:PKPBO_00133	Protein Binding	"Binding, Protein"	Distribution		"The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments"	"Process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds."	http://purl.bioontology.org/ontology/MESH/D011485		0000-0001-8345-1349	0000-0002-9795-5967		Class	Distribution				
pkpbo:PKPBO_00134	Unbound fraction	Fraction Unbound	PK	FU	The fraction of a xenobiotic that is unbound in plasma	The fraction of a xenobiotic that is unbound in plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Distribution				
pkpbo:PKPBO_00135	fugut	gut fraction unbound   	Fraction Unbound 	Fu gut	The fraction of a xenobiotic that is unbound in gut	The fraction of a xenobiotic that is unbound in gut			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00136	fustomach	stomach free fraction	Fraction Unbound 	fustomach	The fraction of a xenobiotic that is unbound in stomach	The fraction of a xenobiotic that is unbound in stomach			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00137	fuintestine	Intestine fraction unbound   	Fraction Unbound 	fuintestine	The fraction of a xenobiotic that is unbound in intestine	The fraction of a xenobiotic that is unbound in intestine			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00138	fupancreas	Pancreas fraction unbound   	Fraction Unbound 	fupancreas	The fraction of a xenobiotic that is unbound in pancreas	The fraction of a xenobiotic that is unbound in pancreas			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00139	fuliver	Liver fraction unbound   	Fraction Unbound 	fuliver	The fraction of a xenobiotic that is unbound in liver	The fraction of a xenobiotic that is unbound in liver			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00140	fukidney	Kidney fraction unbound   	Fraction Unbound 	fukidney	The fraction of a xenobiotic that is unbound in kidney	The fraction of a xenobiotic that is unbound in kidney			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00141	fumuscle	Muscle fraction unbound   	Fraction Unbound 	fumuscle	The fraction of a xenobiotic that is unbound in muscle	The fraction of a xenobiotic that is unbound in muscle			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00142	fuheart	Cardiac fraction unbound   	Fraction Unbound 	fuheart	The fraction of a xenobiotic that is unbound in heart	The fraction of a xenobiotic that is unbound in heart			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00143	fufat	Fat fraction unbound   	Fraction Unbound 	fufat	The fraction of a xenobiotic that is unbound in fat	The fraction of a xenobiotic that is unbound in fat			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00144	fugonads	Gonads fraction unbound   	Fraction Unbound 	fugonads	The fraction of a xenobiotic that is unbound in gonads	The fraction of a xenobiotic that is unbound in gonads			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00145	fuskin	Skin fraction unbound	Fraction Unbound 	fuskin	The fraction of a xenobiotic that is unbound in skin	The fraction of a xenobiotic that is unbound in skin			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00146	fubone	Bone fraction unbound	Fraction Unbound 	fubone	The fraction of a xenobiotic that is unbound in bone	The fraction of a xenobiotic that is unbound in bone			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00147	fuspleen	Spleen fraction unbound	Fraction Unbound 	fuspleen	The fraction of a xenobiotic that is unbound in spleen	The fraction of a xenobiotic that is unbound in spleen			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00148	fulung	Lung fraction unbound	Fraction Unbound 	fulung	The fraction of a xenobiotic that is unbound in lung	The fraction of a xenobiotic that is unbound in lung			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00149	fuenterocytes	RBC fraction unbound	Fraction Unbound	fuenterocytes	The fraction of a xenobiotic that is unbound in enterocyte	The fraction of a xenobiotic that is unbound in enterocyte			0000-0001-8345-1349	0000-0002-9795-5967		Class	Unbound fraction				
pkpbo:PKPBO_00150	Partition coefficient		Partition coefficient	Kp	The ratio of the concentration of a drug/chemical in a particular tissue to its concentration in plasma at equilibrium. It is also known as tissue-to-plasma partition coefficient	The ratio of the concentration of a drug/chemical in a particular tissue to its concentration in plasma at equilibrium. It is also known as tissue-to-plasma partition coefficient	10.1124/dmd.120.090498		0000-0001-8345-1349	0000-0002-9795-5967		Class	Distribution				
pkpbo:PKPBO_00151	gut:plasma	k_gut_plasma	Partition coefficient	k_gut_plasma	Partition coefficient of gut to plasma	Partition coefficient of gut to plasma	https://doi.org/10.1016/j.toxlet.2023.06.006		0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00152	Stomach:Plasma	k_Stomach_plasma	Partition coefficient	k_Stomach_plasma	Partition coefficient of stomach to plasma	Partition coefficient of stomach to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00153	Intestine:Plasma	k_Intestine_plasma	Partition coefficient	k_Intestine_plasma	Partition coefficient of intestine to plasma	Partition coefficient of intestine to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00154	Pancreas:Plasma	k_Pancreas_plasma	Partition coefficient	k_Pancreas_plasma	Partition coefficient of pancreas to plasma	Partition coefficient of pancreas to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00155	Liver:Plasma	k_Liver_plasma	Partition coefficient	k_Liver_plasma	Partition coefficient of liver to plasma	Partition coefficient of liver to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00156	Kidney: Plasma	k_Kidney_plasma	Partition coefficient	k_Kidney_plasma	Partition coefficient of kidney to plasma	Partition coefficient of kidney to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00157	Muscle:Plasma	k_Muscle_plasma	Partition coefficient	k_Muscle_plasma	Partition coefficient of muscle to plasma	Partition coefficient of muscle to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00158	Heart:Plasma	k_Heart_plasma	Partition coefficient	k_Heart_plasma	Partition coefficient of heart to plasma	Partition coefficient of heart to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00159	Fat:Plasma	k_fat_plasma	Partition coefficient	k_fat_plasma	Partition coefficient of fat to plasma	Partition coefficient of fat to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00160	Gonads:Plasma	k_gonads_plasma	Partition coefficient	k_gonads_plasma	Partition coefficient of gonads to plasma	Partition coefficient of gonads to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00161	Skin:Plasma	k_skin_plasma	Partition coefficient	k_skin_plasma	Partition coefficient of skin to plasma	Partition coefficient of skin to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00162	Bone:Plasma	k_bone_plasma	Partition coefficient	k_bone_plasma	Partition coefficient of bone to plasma	Partition coefficient of bone to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00163	Spleen:Plasma	k_spleen_plasma	Partition coefficient	k_spleen_plasma	Partition coefficient of spleen to plasma	Partition coefficient of spleen to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00164	Lung:plasma	k_lung_plasma	Partition coefficient	k_lung_plasma	Partition coefficient of lung to plasma	Partition coefficient of lung to plasma			0000-0001-8345-1349	0000-0002-9795-5967		Class	Partition coefficient				
pkpbo:PKPBO_00165	Human serum albumin	Serum albumin		HSA	"Human serum albumin (HSA) is a protein made by the liver and is the most abundant protein in human blood plasma, representing about half of the total protein content"	"Human serum albumin (HSA) is a protein made by the liver and is the most abundant protein in human blood plasma, representing about half of the total protein content"	Human serum albumin - Wikipedia		0000-0001-8345-1349	0000-0002-9795-5967		Class	Distribution				
pkpbo:PKPBO_00166	alpha acid glycoprotein	orosomucoid		AAG	"Alpha-1-acid glycoprotein (AAG), also known as orosomucoid, is a globulin with a molecular weight of about 44,000 Da."	"Orosomucoid, ,i.s  globulin with a molecular weight of 44,000 Da."	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter-11, page number-275"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Distribution				
pkpbo:PKPBO_00167	Blood:Plasma ratio	Blood to plasma ratio	ratio endpoint	CB/CP	The ratio of the concentration of molecule in whole blood (i.e. contains both red blood cells and plasma) to the concentration of molecule in plasma	Ratio of concentration of molecule in whole blood (contains both red blood cells and plasma) to concentration of molecule in plasma	http://www.bioassayontology.org/bao#BAO_0080043		0000-0001-8345-1349	0000-0002-9795-5967		Class	Distribution				
pkpbo:PKPBO_00168	Metabolism	Bio transformation	PK	M	"The process of drug or chemical transformation within the body, typically involving enzymatic reactions leading to formation of active metabolite, inactivation of parent compound or formation of toxic by-products"	"The process of drug or chemical transformation within the body, typically involving enzymatic reactions leading to formation of active metabolite, inactivation of parent compound or formation of toxic by-products"	10.3390/ijerph20043473		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biochemical Parameters				
pkpbo:PKPBO_00169	catalytic rate constant	"kcat
turnover number"	Xenoboitic metabolism	kcat	Numerical parameter that quantifies the velocity of an enzymatic reaction	"Numerical parameter that quantifies  an enzymatic reaction velocity.or
Maximum number of substrate molecules converted to products per active site per unit time."	"http://purl.obolibrary.org/obo/SBO_0000025
http://www.bioassayontology.org/bao#BAO_0000481"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00170	Ontogeny				The incorporation of age-related changes in physiology and anatomy into the modeling of drug pharmacokinetics	The incorporation of age-related changes in physiology and anatomy into the modeling of drug pharmacokinetics	10.1002/jcph.1489		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00171	Phase I	Phase I metabolism	Xenoboitic metabolism		"The phase I biotransformation pathway involves the conversion of exogenous substances to more polar metabolites. Members of the cytochrome P450 superfamily and to a lesser extent, flavin-containing monooxygenases mediate the reactions."	Phase I biotransformation involves  conversion of exogenous substances to more polar metabolites by cytochrome P450 superfamily.	http://purl.obolibrary.org/obo/PW_0000857		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00172	CYP enzymes		Xenoboitic metabolism		"The P450s are heme b-containing enzymes
that bind and reduce molecular oxygen, leading to
(usually) mono-oxygenation of substrate and production
of a molecule of water."	"The P450s are heme b-containing enzymes
that bind and reduce molecular oxygen, leading to
(usually) mono-oxygenation of substrate and production
of a molecule of water."	https://sci-hub.hkvisa.net/10.1016/s1472-9792(03)00051-9		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase I				
pkpbo:PKPBO_00173	CYP1A2	"P3-450
P450(PA)
CP12"	Xenoboitic metabolism	CYP1A2	"CYPIA2|P450 form 4|aryl hydrocarbon hydroxylase|cytochrome P(3)450|cytochrome P450 1A2|cytochrome P450 4|cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2|cytochrome P450-P3|dioxin-inducible P3-450|flavoprotein-linkedmonooxygenase|microsomal monooxygenase|xenobiotic monooxygenase"	"CYPIA2|P450 form 4|aryl hydrocarbon hydroxylase|cytochrome P(3)450|cytochrome P450 1A2|cytochrome P450 4|cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2|cytochrome P450-P3|dioxin-inducible P3-450|flavoprotein-linked monooxygenase|microsomal monooxygenase|xenobiotic monooxygenase"	http://www.ncbi.nlm.nih.gov/gene		0000-0001-8345-1349	0000-0002-9795-5967		Class	CYP enzymes				
pkpbo:PKPBO_00174	Cytochrome P-450 CYP2E1	CYP 2E1	Xenoboitic metabolism	CYP 2E1	"An ethanol-inducible cytochrome P450 enzyme that metabolizes several precarcinogens, Xenoboitics, and solvents to reactive metabolites."	"An ethanol-inducible cytochrome P450 enzyme that metabolizes several precarcinogens, Xenoboitics, and solvents to reactive metabolites."	http://purl.bioontology.org/ontology/NDFRT/N0000170046		0000-0001-8345-1349	0000-0002-9795-5967		Class	CYP enzymes				
pkpbo:PKPBO_00175	Cytochrome P-450 CYP3A4		Xenoboitic metabolism	CYP3A4	"Cytochrome P450, family 3, subfamily A; polypeptide 4. A heme-thiolate monooxygenase.
'CYP3A4' as the symbol for the gene that codes this protein."	"Cytochrome P450, family 3, subfamily A; polypeptide 4. A heme-thiolate monooxygenase."	"http://purl.org/net/Xenoboitic-interaction-knowledge-base/DIKB_evidence_ontology.owl#CYP3A4
  http://purl.obolibrary.org/obo/NCIT_C24328"		0000-0001-8345-1349	0000-0002-9795-5967		Class	CYP enzymes				
pkpbo:PKPBO_00176	Cytochrome P-450 CYP2D6	"cyp2d6-a
cyp2d2"	Xenoboitic metabolism	CYP2D6	"Cytochrome P450, family 2, subfamily D, polypeptide 6. A heme-thiolate monooxygenase.  'CYP2D6' as the symbol for the gene that codes this protein."	"Cytochrome P450, family 2, subfamily D, polypeptide 6. A heme-thiolate monooxygenase."	"http://purl.org/net/Xenoboitic-interaction-knowledge-base/DIKB_evidence_ontology.owl#CYP2D6
http://purl.obolibrary.org/obo/OGG_3000001565
http://purl.obolibrary.org/obo/NCBIGene_446878"		0000-0001-8345-1349	0000-0002-9795-5967		Class	CYP enzymes				
pkpbo:PKPBO_00177	Cytochrome P-450 CYP2C9	"CYPIIC9
CYP2C
CYP2C10
CPC9
P450IIC9"	Xenoboitic metabolism	CYP2C9	"Cytochrome P450, family 2, subfamily C, polypeptide 9.  located on the chromosome 10 mapped at 10q24. A heme-thiolate monooxygenase.  The HUGO Gene Nomenclature Committee (HGNC) database uses 'CYP2C9' as the symbol for the gene that codes this protein."	"Cytochrome P450, family 2, subfamily C, polypeptide 9.  A heme-thiolate monooxygenase."	"http://purl.org/net/Xenoboitic-interaction-knowledge-base/DIKB_evidence_ontology.owl#CYP2C9
http://purl.obolibrary.org/obo/NCBIGene_1559"		0000-0001-8345-1349	0000-0002-9795-5967		Class	CYP enzymes				
pkpbo:PKPBO_00178	Cytochrome p450 CYP3A7	"CP37
P-450111A7
P450-HFLA
P-450(HFL33)
CYPIIIA7"	Xenoboitic metabolism	CYP3A7	"The protein-coding gene CYP3A7 (cytochrome P450, family 3, subfamily A, polypeptide 7) located on the chromosome 7 mapped at 7q21-q22.1. or
Aryl hydrocarbon hydroxylase|cytochrome P450 3A7|cytochrome P450, subfamily IIIA, polypeptide 7|cytochrome P450-HFLA|flavoprotein-linked monooxygenase|microsomal monooxygenase|xenobiotic monooxygenase"	"Cytochrome P450, family 3, subfamily A, polypeptide 7) located on chromosome 7 mapped at 7q21-q22.1."	"http://identifiers.org/ncbigene/1551

http://purl.obolibrary.org/obo/OGG_3000001551"		0000-0001-8345-1349	0000-0002-9795-5967		Class	CYP enzymes				
pkpbo:PKPBO_00179	CYP2C8	"CPC8
MP-12|MP-20
CYPIIC8"	Xenoboitic metabolism	CYP2C8	"The protein-coding gene CYP2C8 (cytochrome P450, family 2, subfamily C, polypeptide 8) located on the chromosome 10 mapped at 10q23.33. Or
Cytochrome P450 plays a role in oxidation of both endobiotics and xenobiotics metabolism."	"Cytochrome P450, family 2, subfamily C, polypeptide 8) located on chromosome 10 mapped at 10q23.33."	"http://identifiers.org/ncbigene/1558

http://purl.obolibrary.org/obo/NCIT_C46071"		0000-0001-8345-1349	0000-0002-9795-5967		Class	CYP enzymes				
pkpbo:PKPBO_00180	Phase II	Phase I metabolism	Xenoboitic metabolism		The phase II biotransformation pathway involves the conjugation of phase I products to various hydrophilic moieties that renders them more suitable for excretion. Various enzyme superfamilies are involved in carrying out the specific conjugation of metabolites	"It involves conjugation of phase I products to various hydrophilic moieties that renders them more suitable for excretion.or
Phase II, subtype of  metabolic biotransformation reactions involving conjugate enabling efficient excretion."	http://purl.obolibrary.org/obo/PW_0000858		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00181	UGT1A1	"UDPGT
HUG-BR1
GNT1
UGT1A
BILIQTL1
UDPGT 1-1
UGT1"	Xenoboitic metabolism	UGT1A1	"The protein-coding gene UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) located on the chromosome 2 mapped at 2q37."	"UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) located on  chromosome 2 mapped at 2q37."	http://purl.obolibrary.org/obo/NCBIGene_54658		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00182	UGT1A4	"UDPGT
UGT1-04
UDPGT 1-4
UGT-1D
UGT1D
UGT1.4
HUG-BR2"	Xenoboitic metabolism	UGT1A4	"The protein-coding gene UGT1A4 (UDP glucuronosyltransferase 1 family, polypeptide A4) located on the chromosome 2 mapped at 2q37."	"UDP Glucuronosyltransferase 1 Family, Polypeptide A4 Gene involved in xenobiotic metabolism."	"http://identifiers.org/ncbigene/54657
http://purl.obolibrary.org/obo/OMIT_0042415"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00183	UGT1A6	"UDPGT
GNT1
UGT1F
HLUGP1
UGT1
UGT1A6S
UDPGT 1-6
HLUGP"	Xenoboitic metabolism	UGT1A6	"The protein-coding gene UGT1A6 (UDP glucuronosyltransferase 1 family, polypeptide A6) located on the chromosome 2 mapped at 2q37."		http://identifiers.org/ncbigene/113992		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00184	UGT1A9	"HLUGP4
UGT1-09
UGT1AI
UDPGT 1-9
UGT1.9
UDPGT
UGT1-9
LUGP4
UGT-1I
UGT1I"	Xenoboitic metabolism	UGT1A9	"The protein-coding gene UGT1A9 (UDP glucuronosyltransferase 1 family, polypeptide A9) located on the chromosome 2 mapped at 2q37."	"UGT1A9 (UDP glucuronosyltransferase 1 family, polypeptide A9)  is involved in phenol detoxification"	"http://identifiers.org/ncbigene/54600
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105862"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00185	UGT2B4	"HLUG25
UGT2B11
UDPGTH1
UDPGT2B4
UDPGTh-1"	Xenoboitic metabolism	UGT2B4	"The protein-coding gene UGT2B4 (UDP glucuronosyltransferase 2 family, polypeptide B4) located on the chromosome 4 mapped at 4q13."	"UGT2B4 (UDP glucuronosyltransferase 2 family, polypeptide B4) located on  chromosome 4 mapped at 4q13. or
UDP glucuronosyltransferase family 2 member B4."	"http://identifiers.org/ncbigene/7363
 

http://purl.obolibrary.org/obo/OMIT_0036009"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00186	UGT2B7	"UDPGT 2B9
UGT2B9
UDPGTH2
UDPGT2B7"	Xenoboitic metabolism	UGT2B7	"The protein-coding gene UGT2B7 (UDP glucuronosyltransferase 2 family, polypeptide B7) located on the chromosome 4 mapped at 4q13."	"UDP glucuronosyltransferase 2 family, polypeptide B7"	"http://purl.obolibrary.org/obo/NCBIGene_7364
http://purl.obolibrary.org/obo/OGG_3000007364"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00187	SULT	"Sult-x1
Sultx1"	Xenoboitic metabolism	SULT	"The protein-coding gene Sult5a1 (sulfotransferase family 5A, member 1) located on the chromosome 8 mapped at 8 E1|8."	"Sult5a1 (sulfotransferase family 5A, member 1) located on the chromosome 8 mapped at 8 E1|8."	http://purl.obolibrary.org/obo/NCBIGene_57429		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00188	NAT 2	nhoA	Xenoboitic metabolism	NAT 2		Arylamine N-acetyltransferase Nat (arylamine acetylase)	http://www.ncbi.nlm.nih.gov/gene		0000-0001-8345-1349	0000-0002-9795-5967		Class	Phase II				
pkpbo:PKPBO_00189	Phase III				"Occurs post-phase II, where xenobiotics can undergo further metabolism and excretion. It classifies into the following superfamilies: ATP-binding cassette (ABC), Solute carrier (SLC) transporters"	"Occurs post-phase II, where xenobiotics can undergo further metabolism and excretion"	https://www.ncbi.nlm.nih.gov/books/NBK544353/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00190	First pass metabolism	First pass effect	Metabolism		"First pass metabolism, also known as the first pass effect or presystemic metabolism, is a phenomenon in which a drug/chemical undergoes metabolism at a specific location in the body, resulting in a reduced concentration of the active drug/chemical before it reaches its site of action or systemic circulation. "	"First pass metabolism, also known as the first pass effect or presystemic metabolism, is a phenomenon in which a drug/chemical undergoes metabolism at a specific location in the body, resulting in a reduced concentration of the active drug/chemical before it reaches its site of action or systemic circulation. "	First Pass Effect - StatPearls - NCBI Bookshelf (nih.gov)		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00191	Vmax_intestine		Metabolism		"The maximum rate of metabolic reaction, when all the enzyme s active sites are saturated with substrate in intestine"	"Maximum rate of metabolic reaction, when all enzyme s active sites are saturated with substrate in intestine"	https://teachmephysiology.com/biochemistry/molecules-and-signalling/enzyme-kinetics/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00192	Km_intestine	Michaelis constant_intestine	Metabolism		"The substrate concentration at which the reaction rate is 50% of the Vmax in intestine. Km is a measure of the affinity an enzyme has for its substrate, as the lower the value of Km, the more efficient the enzyme is at carrying out its function at a lower substrate concentration."	Substrate concentration at which reaction rate is 50% of Vmax in intestine	https://teachmephysiology.com/biochemistry/molecules-and-signalling/enzyme-kinetics/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00193	Vmax_liver		Metabolism		"The maximum rate of metabolic reaction, when all the enzyme s active sites are saturated with substrate in Liver"	"Maximum rate of metabolic reaction, when all enzyme s active sites are saturated with substrate in Liver"	https://teachmephysiology.com/biochemistry/molecules-and-signalling/enzyme-kinetics/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00194	Km_liver	Michaelis constant_liver	Metabolism		The substrate concentration at which the reaction rate is 50% of the Vmax in liver	Substrate concentration at which reaction rate is 50% of Vmax in liver	https://teachmephysiology.com/biochemistry/molecules-and-signalling/enzyme-kinetics/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00195	Gut Metabolism				The metabolism of a xenoboitic that occurs in the gut	The metabolism of a xenoboitic that occurs in gut			0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00196	kd				"KD in PBPK modeling refers to the dissociation constant of a drug/chemical-receptor complex, which is a measure of the affinity of the drug/chemical for its target receptor. It affects the distribution and elimination of the drug/chemical in the body. The dissociation constant (KD) is defined as the ratio of the rate constants for the forward and reverse reactions of the drug/chemical-receptor complex. "	"KD in PBPK modeling refers to the dissociation constant of a drug/chemical-receptor complex, which is a measure of the affinity of the drug/chemical for its target receptor. It affects the distribution and elimination of the drug/chemical in the body. The dissociation constant (KD) is defined as the ratio of the rate constants for the forward and reverse reactions of the drug/chemical-receptor complex. "	10.1186/s13550-021-00821-7		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00197	Transporters				"Xenobiotic transporters are responsible for the uptake of some chemicals into cells, and extremely important for the export of chemicals out of cells"	Responsible for import or export xenobiotics in or out of cell	https://pubmed.ncbi.nlm.nih.gov/11936902/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00198	OATP	"Organic Anion Transporting Polypeptide
SLCO
Solute Carrier Organic Anion
Organic Anion Transporter Protein
OATP
Organic Anion-Transporting Polypeptide
Organic Anion Transporter
Organic Anion Transport Protein"	Protiens		A family of transmembrane proteins that play a role in the transport of organic anions including bile acids and bilirubin.	Family of transmembrane proteins that transport of organic anions including bile acids and bilirubin	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C107150		0000-0001-8345-1349	0000-0002-9795-5967		Class	Transporters				
pkpbo:PKPBO_00199	Abcc3	"ATP-Binding Cassette, Sub-Family C (CFTR/MRP), Member 3 wt Allele
MLP2
EST90757
cMOAT2
MOAT-D
ABCC3 wt Allele
MRP3
ABC31"	Protiens	ABCC3	"Human ABCC3 wild-type allele is located in the vicinity of 17q22 and is approximately 57 kb in length. This allele, which encodes canalicular multispecific organic anion transporter 2 protein, plays a role in bile metabolism and transport"	"Human ABCC3 wild-type allele is located in vicinity of 17q22 and is approximately 57 kb in length, plays a role in bile metabolism and transport"	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C106022		0000-0001-8345-1349	0000-0002-9795-5967		Class	Transporters				
pkpbo:PKPBO_00200	Abcc2	"DJS
CMOAT
ABC30
MRP2
cMRP"	Protiens	ABCC2	"The protein-coding gene ABCC2 (ATP-binding cassette, sub-family C (CFTR|MRP), member 2) located on the chromosome 10 mapped at 10q24"	Protein-coding gene ABCC2 located on chromosome 10 mapped at 10q24	http://identifiers.org/ncbigene/1244		0000-0001-8345-1349	0000-0002-9795-5967		Class	Transporters				
pkpbo:PKPBO_00201	kdeg	degradation rate constant	Enzyme		Degradation rate constant of metabolizing enzyme	Degradation rate constant of metabolizing enzyme	Guideline on the reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation (europa.eu)	Guideline on the reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation (europa.eu)	0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00202	ki	The inhibitory constant	equilibrium dissociation constant (Kd)	ki	inhibition constant for a specific enzyme or transporter	inhibition constant for a specific enzyme or transporter	Guideline on the reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation (europa.eu)		0000-0001-8345-1349	0000-0002-9795-5967		Class	Metabolism				
pkpbo:PKPBO_00203	Excretion			E	"Excretion in PBPK refers to the removal of a compound from the body through various routes such as urine, feces, exhalation etc."	"Removal of a compound from the body through various routes such as urine, feces, and exhalation"	10.3390/ijerph20043473		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biochemical Parameters				
pkpbo:PKPBO_00204	Renal excretion		Excretion		"The process by which xenoboitics and their metabolites are eliminated from the body, primarily through urine."	"Process by which xenoboitics and their metabolites are eliminated from body, primarily through urine."	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015. Chapter 7, Page Number-149"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00205	Heaptic Excretion	Hepatic clearance	Excretion		"The process by which xenoboitics and their metabolites are eliminated from the body, through liver metabolic processes."	Removing  xenoboitic fraction from liver.			0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00206	Fecal excretion	Intestinal clerance	Excretion		"The process by which xenoboitics and their metabolites are eliminated from the body, through feces"	Removing chemical and its metabolites through feces			0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00207	Exhalation	Lung clearance	Excretion		Exhalation defines as the removing chemical and its metabolites through respiration (Inhalation and exhalation process.	Removing chemical and its metabolites through respiration			0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00208	Sweat excretion	Sweat glands excretion	Excretion		Sweat excretion defined as the  removing chemical and its metabolites through sweat.	Removing chemical and its metabolites through sweat.			0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00209	Hair excretion		Excretion		Hair excretion defined as the  removing chemical and its metabolites through hair.	Removing chemical and its metabolites through hair.			0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00210	Clearance		Excretion	Cl	Clearance  defined as the volume of fluid cleared of xenoboitic from the body per unit of time. 	Volume of fluid cleared of xenoboitic from body per unit  time. 	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015."		0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00211	Fecal clearance		Excretion		Fecal Clearance  defined as the fecal cleared volume of  xenoboitic from the body per unit of time. 	 Fecal cleared volume of  xenoboitic from body per unit  time. 	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015."		0000-0001-8345-1349	0000-0002-9795-5967		Class	Clearance				
pkpbo:PKPBO_00212	sweat clearance		Excretion		Sweat Clearance  defined as the sweat cleared volume xenoboitic from the body per unit of time. 	 Sweat cleared volume of  xenoboitic from body per unit  time. 	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter 7, Page Number-152"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Clearance				
pkpbo:PKPBO_00213	urinary clearance		Excretion		Urinary clearance  defined as the urine cleared volume xenoboitic from the body per unit of time. 	 Urine cleared volume of  xenoboitic from body per unit time. 	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter 7, Page Number-153"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Clearance				
pkpbo:PKPBO_00214	biliary clearance		Excretion		Biliary clearance  defined as the bile cleared volume xenoboitic from the body per unit of time. 	 Bile cleared volume of  xenoboitic from body per unit time. 	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter 7, Page Number-154"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Clearance				
pkpbo:PKPBO_00215	heaptic clearance		Excretion		Hepatic Clearance  defined as the Liver cleared volume xenoboitic from the body per unit of time. 	 Liver cleared volume of  xenoboitic from body per unit time. 	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter 7, Page Number-155"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Clearance				
pkpbo:PKPBO_00216	intrinsic clearance		Excretion	Clint	"Intrinsic clearance in PBPK refers to the rate at which a compound is metabolized or eliminated by a specific organ or tissue, independent of the concentration of the compound in the blood"	"the rate at which a compound is metabolized or eliminated by a specific organ or tissue, independent of the concentration of the compound in the blood"	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter 7, Page Number-354"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Clearance				
pkpbo:PKPBO_00217	fecal elimination rate constant				the rate at which a compound is eliminated from the body through fecal excretion	the rate at which a compound is eliminated from the body through fecal excretion			0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00218	Renal elimination rate constant				the rate at which a compound is eliminated from the body through urine excretion	the rate at which a compound is eliminated from the body through urine excretion			0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00219	Biliary elimination	biliary excretion			Irreversible transfer of Xenoboitic or Xenoboitic metabolites from the plasma to the bile through the hepatocytes	Irreversible transfer of Xenoboitic or Xenoboitic metabolites from plasma to the bile through hepatocytes	https://sepia2.unil.ch/pharmacology/mechanisms/biliary-excretion/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Excretion				
pkpbo:PKPBO_00220	Route of exposure	Exposure Route of Administration			Designation of the part of the body through which the exposure is introduced.	Designated body part through which exposure is introduced	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C83121		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00221	oral				administration to or by way of the mouth	administration to or by way of mouth	http://radlex.org/RID/RID11173		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00222	dermal				exposure through the skin	exposure through the skin	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25478		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00223	Inhalation	"Inhaled, Inhale"			exposure through breath	exposure through breath	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95464		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00224	intravenous bolus			IVB	"Type of IV therapy where a single dose of medication/chemical/ nutrients is administered over a short period of time, typically less than 30 minutes"	"Type of IV therapy where a single dose of medication/chemical/ nutrients is administered over a short period of time, typically less than 30 minutes"	IV Bolus vs. IV Push | Mobile IV Nurses		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00225	intravenous infusion			IVI	"The administration of fluids, medication, nutrition, or blood directly into the bloodstream through a vein"	"The administration of fluids, medication, nutrition, or blood directly into the bloodstream through a vein"	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38275		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00226	intramuscular				Administration within a muscle	Administration within a muscle	http://radlex.org/RID/RID11139		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00227	intraarterial				The administration of a substance directly into an artery	Administration within an artery or arteries	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38222		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00228	intrathecal				"Inside the spinal canal (the canal in successive vertebrae through which the spinal cord passes-Wordnet definition) . For example, intrathecal immunoglobulin production means production of this substance in the spinal cord; intrathecal injection is an injection into the the spinal canal (intrathecal space surrounding the spinal cord), as in a spinal anaesthesia or in chemotherapy or pain management applications."	Administration inside spinal canal	http://uri.neuinfo.org/nif/nifstd/nlx_inv_090911		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00229	subcutaneous	Subcutaneous (intended site)			An intended site for xenobiotics that is for administration into the subcutaneous tissue	site for administration of xenobiotics into subcutaneous tissue	http://purl.bioontology.org/ontology/SNOMEDCT/764295003		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00230	nasal				administration to the nose; administered by way of the nose.	Administration to the nose or via way of nose	http://radlex.org/RID/RID11169		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00231	transdermal				Administration through the dermal layer of the skin to the systemic circulation by diffusion	Administration through skin dermal layer to systemic circulation by diffusion	http://radlex.org/RID/RID11193		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00232	ocular				An intended site for xenobiotics that is for administration to the eye or eye structures	Site for xenobiotics administration to eye or eye structures	http://purl.bioontology.org/ontology/SNOMEDCT/738952007		0000-0001-8345-1349	0000-0002-9795-5967		Class	Route of exposure				
pkpbo:PKPBO_00233	Output parameters				Refers to result or predictions generated by the model in PBPK	Refers to result or predictions generated by the model in PBPK			0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00234	Peak Concentration	Cumulative concentration		Cmax	"The highest concentration of a drug/chemical in the blood, cerebrospinal fluid, or target organ after exposure"	"The highest concentration of a drug/chemical in the blood, cerebrospinal fluid, or target organ after exposure"	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015."		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00235	Cmaxss				Maximum steady state concentration	Maximum steady state concentration			0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00236	Tmax	Peak plasma xenoboitic level		Tmax	The time required to reach maximum xenoboitic concentration after xenoboitic administration	The time required to reach maximum xenoboitic concentration after xenoboitic administration	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015."		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00237	Area under curve	Total exposure		AUC	It is the definite integral of the concentration of a drug/chemical in blood or plasma as a function of time	It is the definite integral of the concentration of a drug/chemical in blood or plasma as a function of time	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015, Chaper-2,page number-37."		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00238	AUC0-t	observed AUC			the area under the concentration-time curve from dosing (time 0) to the last quantifiable time point (t)	the area under the concentration-time curve from dosing (time 0) to the last quantifiable time point (t)	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015, Chaper-7, page number-154."		0000-0001-8345-1349	0000-0002-9795-5967		Class	Area under curve				
pkpbo:PKPBO_00239	AUClast				the area under the concentration-time curve from dosing (time 0) to the time of the last measured concentration of a drug.	the area under the concentration-time curve from dosing (time 0) to the time of the last measured concentration of a drug.	https://pubmed.ncbi.nlm.nih.gov/22673011/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Area under curve				
pkpbo:PKPBO_00240	AUC0-infinity				"the area under the concentration-time curve from dosing (time 0) to infinity, which means the total drug/chemical exposure across time"	"the area under the concentration-time curve from dosing (time 0) to infinity, which means the total drug/chemical exposure across time"	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015, Chaper-4, page number-79."		0000-0001-8345-1349	0000-0002-9795-5967		Class	Area under curve				
pkpbo:PKPBO_00241	Area under moment curve	First movement area		AUMC	AUMC is a pharmacokinetic parameter that is calculated by measuring the concentration of a drug/chemical in blood plasma as a function of time and then taking the definite integral of the product of time and concentration squared	AUMC is a pharmacokinetic parameter that is calculated by measuring the concentration of a drug/chemical in blood plasma as a function of time and then taking the definite integral of the product of time and concentration squared	10.1111/bcp.12685		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00242	Mean residence time			MRT	Average time a drug/chemical molecule resides in the body	Average time a drug/chemical molecule resides in the body	Mean Residence Time (MRT): Understanding How Long Drug Molecules Stay in the Body | Certara		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00243	half-life	Half Life		t1/2	the time it takes for the concentration of a drug/chemical in the body to decrease by half	the time it takes for the concentration of a drug/chemical in the body to decrease by half	What is a Half-life? | Certara		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00244	bioavailavility	Absorption fraction		F	" Bioavailability is defined as the rate and extent to which the active ingredient or active moiety is absorbed from a Xenoboitic product and becomes available at the site of action (US-FDA, CDER, 2014a)."	" Bioavailability is defined as the rate and extent to which the active ingredient or active moiety is absorbed from a Xenoboitic product and becomes available at the site of action (US-FDA, CDER, 2014a)."	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.
Chapter 16, Page Number-471 "		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00245	Relative bioavailability	Comparative/formulation bioavailability		F rel	"Relative bioavailability is a term used to describe the extent and rate at which a drug/chemical is absorbed into the systemic circulation after administration compared to a reference formulation/source chemical,"	"Relative bioavailability is a term used to describe the extent and rate at which a drug/chemical is absorbed into the systemic circulation after administration compared to a reference formulation/source chemical,"	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.
Chapter 16, Page Number-473"		0000-0001-8345-1349	0000-0002-9795-5967		Class	bioavailavility				
pkpbo:PKPBO_00246	Mean absorption time			MAT	Average time it takes for drug/chemical to be absorbed into systemic circulation	Average time it takes for drug/chemical to be absorbed into systemic circulation	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter-25,Page number-837"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00247	Mean dissolution time			MDT	Average time it takes for drug/chemical to dissolve in body	Average time it takes for drug/chemical to dissolve in body	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.
Chapter-25,Page number-837"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00248	Bioequivalence			BE	 Bioequivalence is defined as the absence of a significant difference in the rate and extent to which the chemical ingredient or moiety becomes available at the site of action when administered at the same molar dose under similar conditions.	Identical comparison between test (T) and reference (R) xenoboitic product	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015.Chapter 16, Page Number-471 "		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00249	absolute bioavailability	FABS	Bioavailability	FABS	Fraction of treatment dose that reaches systemic circulation and ratio of xenobiotics amount in system after administration of a test xenobiotics to xenobiotics in system after IV administration	Fraction of treatment dose that reaches systemic circulation and ratio of xenobiotics amount in system after administration of a test xenobiotics to xenobiotics in system after IV administration	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C154838		0000-0001-8345-1349	0000-0002-9795-5967		Class	bioavailavility				
pkpbo:PKPBO_00250	elimination phase				The elimination phase is a phase in PBPK that describes the process of removing an administered drug/chemical from the body		Distribution and Elimination Phase   Pharmacokinetics (unil.ch)		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00251	absorption phase				Phase describing how drug/chemical goes in systemic circulation from site of administration	Phase describing how drug/chemical goes in systemic circulation from site of administration	Drug Absorption - Clinical Pharmacology - Merck Manuals Professional Edition		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00252	CL/F				describes the rate at which a drug/chemical is eliminated from the body after oral administration	describes the rate at which a drug/chemical is eliminated from the body after oral administration	tcp.2015.23.2.42 (tcpharm.org)		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00253	Aurine				Amount of substance present in urine	Amount of substance present in urine			0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00254	Afeces				Amount of substance present in feces	Amount of substance present in feces			0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00255	Cumulative amount in urine				total amount of drug/chemical or metabolite excreted in urine over specific period of time	total amount of drug/chemical or metabolite excreted in urine over specific period of time	"Chapter 19. Cumulative Urinary Excretion | Handbook of Basic Pharmacokinetics  Including Clinical Applications, 7th Edition | PharmacyLibrary"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00256	Cumulative amount in feces				total amount of drug/chemical or metabolite excreted in feces over specific period of time	total amount of drug/chemical or metabolite excreted in feces over specific period of time			0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00257	Creatinine				"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function."	breakdown product of creatine which excreted in urine	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C399		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00258	AUCss				Steady state area under curve				0000-0001-8345-1349	0000-0002-9795-5967		Class	Area under curve				
pkpbo:PKPBO_00259	Plasma concentration					"Xenobiotic concentration in plasma, derived from full blood"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00260	Min Organ Concentration				Minimum organ concentration				0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00261	Max organ concentration				Maximum organ concentration				0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00262	Median Organ concentration				Medium organ concentration				0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00263	Percentile 2.5 plasma concentration				Percentile 2.5 plasma concentration				0000-0001-8345-1349	0000-0002-9795-5967		Class	Plasma concentration				
pkpbo:PKPBO_00264	percetile 97.5 plasma concentration				percetile 97.5 plasma concentration				0000-0001-8345-1349	0000-0002-9795-5967		Class	Plasma concentration				
pkpbo:PKPBO_00265	Tolerable daily intake				"estimate of the amount of a substance in air, food or drinking water that can be taken in daily over a lifetime without appreciable health risk"	"estimate of the amount of a substance in air, food or drinking water that can be taken in daily over a lifetime without appreciable health risk"	Tolerable daily intake - Wikipedia		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00266	Reconstructed exposure				Method used to estimate the eamount of a substance a person has been exposed by using internal body measurements				0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00267	Estimated daily intake				measure used to estimate the amount of a substance that a person consumes daily through food or other sources	measure used to estimate the amount of a substance that a person consumes daily through food or other sources	Guidance for Industry: Estimating Dietary Intake of Substances in Food | FDA		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00268	Biomonitoring equivalent			BE	"The concentration of a chemical (or metabolite) in a biological medium (blood, urine, human milk, etc.) consistent with defined exposure guidance values or toxicity criteria including reference doses and reference concentrations (RfD and RfCs), minimal risk levels (MRLs), or tolerable daily intakes (TDIs)"	"chemical concentration (or metabolite) in biological medium (eg. blood, urine, human milk) consistent with defined exposure guidance values or toxicity criteria including reference doses and reference concentrations, minimal risk levels or tolerable daily intakes"	"Hays S. M., et al. Guidelines for the derivation of biomonitoring equivalents: Report from the biomonitoring equivalents expert workshop. Regulatory Toxicology and Pharmacology V51(3), 2008, Pages S4-S15. https://doi.org/10.1016/j.yrtph.2008.05.004"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00269	HBM-HBGV				Human Biomonitoring Health-Based Guidance Value. It is a measure used to establish safe levels of a substance in blood or urine based on human biomonitoring data	Human Biomonitoring Health-Based Guidance Value. It is a measure used to establish safe levels of a substance in blood or urine based on human biomonitoring data	10.1016/j.envint.2020.105978		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00270	Reference dose			RfD	Estimate (with uncertainty spanning perhaps an order of magnitude) of a daily oral or dermal exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime. Its unit is usually mg/kg bw/day or mg/kg.	Daily oral or dermal exposure estimation to human population (including sensitive subgroups)	https://www.chemsafetypro.com/Topics/CRA/What_is_Point_of_Departure_(POD)_in_Toxicology_and_How_to_Use_It_to_Calculate_Reference_Dose_RfD.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00271	Acceptable daily intake	acceptable daily intake		ADI	"An estimate of the amount of a substance in food or drinking water that can be consumed daily over a lifetime without presenting an appreciable risk to health. It is usually expressed as milligrams of the substance per kilogram of body weight and applies to chemical substances such as food additives, pesticide residues and veterinary Xenoboitics"	Substance in food or drinking water that consumed daily over a lifetime without presenting appreciable risk to health	https://www.efsa.europa.eu/en/glossary/adi		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00272	Human biomonitoring			HBM	An instrument for measuring the internal dose of exogenous substances/chemicals that enter a body during a certain period of exposure from a range of sources	Measuring instrument for internal dose of exogenous substances/chemicals that enter a body during a certain exposure period from different sources	World Health Organization. Regional Office for Europe. (?2023)?. Human biomonitoring. Basics: educational course. World Health Organization. Regional Office for Europe. https://apps.who.int/iris/handle/10665/368163. License: CC BY-NC-SA 3.0 IGO		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00273	Reverse dosimetry	dose reconstruction			An estimation of environmental exposures consistent with measured biological monitoring data	"Environmental exposures estimation, consistent with measured biological monitoring data"	"Ruiz, P., & Fowler, B. A. (2015). Exposure Assessment, Forward and Reverse Dosimetry. Handbook on the Toxicology of Metals, 141 153. doi:10.1016/b978-0-444-59453-2.00007-X"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00274	Forward dosimetry				an estimation of internal exposures from measurements of external exposure in studies characterizing chemical toxicity	Estimation from external exposure mesurements in studies characterizing chemical toxicity	"Ruiz, P., & Fowler, B. A. (2015). Exposure Assessment, Forward and Reverse Dosimetry. Handbook on the Toxicology of Metals, 141 153. doi:10.1016/b978-0-444-59453-2.00007-X"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00275	Spot urine				"single, untimed urine specimen, voided spontaneously by the patient. The sample is analyzed to determine its protein, creatinine, or electrolyte content. This type of specimen differs from a timed urinary specimen, which represents all the urine a patient produces over a 12- or 24-hr period."	"Single, untimed urine specimen, voided spontaneously by patient and is used to determine its protein, creatinine, or electrolyte content"	https://medical-dictionary.thefreedictionary.com/collection%2C+spot+urine		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00276	Specific gravity	Relative Density			"The ratio of the density of a material to the density of some standard material, such as water or air, at a specified temperature."	Ratio of material density to some standard material density like water or air at specified temperature	http://purl.bioontology.org/ontology/MESH/D013046		0000-0001-8345-1349	0000-0002-9795-5967		Class	Output parameters				
pkpbo:PKPBO_00277	Reference human								0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters				
pkpbo:PKPBO_00278	Biological matrix				"A biological matrix is a biological material, such as blood, urine, or tissue, that is used for analysis in scientific research and medical testing"	"A biological matrix is a biological material, such as blood, urine, or tissue, that is used for analysis in scientific research and medical testing"			0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters				
pkpbo:PKPBO_00279	Hair	trichotillomania			"filament-like structure composed of keratin, consisting of a shaft which projects to the surface of the skin from a root which is softer than the shaft and lodges in the cavity of a hair follicle."	"Keratin composed filament-like structure, consisting of shaft, projecting to skin surface from root which is softer than shaft and lodges in hair follicle cavity"	http://purl.bioontology.org/ontology/CSP/2716-0900		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biological matrix				
pkpbo:PKPBO_00280	Nail	"Nail Apparatus, nail/claw"			"A horn-like keratin structure covering the dorsal aspect of the terminal phalanges of fingers and toes.
The cutaneous plate on the dorsal surface of the distal end of a finger or toe."	Cutaneous plate on dorsal surface of distal end of finger or toe	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C33156		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biological matrix				
pkpbo:PKPBO_00281	Teeth	Tooth			One of a set of bone-like structures in the mouth used for biting and chewing	Set of bone-like structures in mouth used for biting and chewing	http://purl.bioontology.org/ontology/MESH/D014070		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biological matrix				
pkpbo:PKPBO_00282	Blood				"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood."	"Liquid tissue which transport oxygen, nutrients, removes waste products, and contains various components of immune system defending body against infection"	http://purl.obolibrary.org/obo/NCIT_C12434		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biological matrix				
pkpbo:PKPBO_00283	Urine				"The fluid produced by the kidneys.
Fluid containing water and waste products. Urine is made by the kidneys, stored in the bladder, and leaves the body through the urethra."	"Fluid, excreted by the kidneys and is stored in bladder and discharged through urethra"	http://purl.obolibrary.org/obo/NCIT_C13283		0000-0001-8345-1349	0000-0002-9795-5967		Class	Biological matrix				
pkpbo:PKPBO_00284	Permeability limited PBPK				"permeability-limited PBPK models consider the permeability of the substance into and out of capillaries, cell membranes, and intracellular lipids. the rate of diffusion across tissue membrane is the limiting factor"		10.1021/acs.est.7b02602		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00285	Vmax_baso_in vitro 				Vmax of basolateral transporter				0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00286	km_baso				km of basolateral transporter				0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00287	Vmax_apical_invitro				Vmax of apical transporter		10.1016/j.envint.2019.03.058		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00288	km_apical				km of apical transporter		10.1016/j.envint.2019.03.058		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00289	RAFapi				Apical transporter		10.1016/j.envint.2019.03.058		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00290	RAFbaso				Basolateral transporters		10.1016/j.envint.2019.03.058		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00291	Kiff				"describe the influx pathway of a chemical, which is the process by which a chemical moves from the extracellular fluid or plasma into a cell"		10.1016/j.envint.2019.03.058		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00292	KeffluxC				"describe the efflux pathway of a chemical, which is the process by which a chemical moves from inside a cell to the extracellular fluid or plasma"		10.1016/j.envint.2019.03.058		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00293	Plasma Space								0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00294	Endosomal Space				"endosomal space is a compartment within the endosomal-lysosomal system, which is a set of intracellular membranous compartments that dynamically interconvert"		10.1186/s40035-015-0041-1		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00295	Interstitial Space				"the fluid-filled space that lies between blood vessels and cells, providing the fluid and structural environment surrounding those cells"		10.3389/fvets.2020.609583		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00296	effective permeability (Peff)	absorptive clearance per unit area		Peff	"Effective permeability is a measure of the rate at which a substance can pass through a barrier, such as a cell membrane or capillary walls"	"Effective permeability is a measure of the rate at which a substance can pass through a barrier, such as a cell membrane or capillary wal"	10.1111/cts.13314		0000-0001-8345-1349	0000-0002-9795-5967		Class	Permeability limited PBPK				
pkpbo:PKPBO_00297	Population PBPK	Bayesian population PBPK approach			"It is considered for the identification of interindividual variability in a population and the characterization of its physiological and ADME (absorption, distribution, metabolization, excretion)-related sources."	"model used for interindividual variability identification in population, its physiological characterization and ADME related sources"	"Krauss M., et al. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations. PLoS ONE 2015. 10(10): e0139423. https://doi.org/10.1371/journal.pone.0139423"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00298	top-down PBPK				"Modelling and simulation approach based on the observed clinical data, mainly empirical with the scope of utilization narrowed down to the range of the input data"	"Modelling and simulation approach based on observed clinical data, empirical with utilization scope, narrowed down to input data range"	"Tylutki, Z. et al. Top-down, Bottom-up and Middle-out Strategies for Xenoboitic Cardiac Safety Assessment via Modeling and Simulations. Curr Pharmacol Rep 2, 171 177 (2016). https://doi.org/10.1007/s40495-016-0060-3"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00299	bottom-up pbpk				"Modelling and simulation approach based on knowledge about the human body, therefore, as mechanistic as possible, utilizing in vitro information as the input data"	"Modelling and simulation approach based on knowledge of human body, therefore, as mechanistic as possible, utilizing in vitro information as input data"	"Tylutki, Z. et al. Top-down, Bottom-up and Middle-out Strategies for Xenoboitic Cardiac Safety Assessment via Modeling and Simulations. Curr Pharmacol Rep 2, 171 177 (2016). https://doi.org/10.1007/s40495-016-0060-3"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00300	one-compartment PBPK				A one-compartment model assumes that all the tissues in the body are contained in a single compartment called the  central compartment.  		Pharmacokinetics & Compartmental Modeling | Allucent		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00301	central compartment				component of a two compartment pharmacokinetic model representing plasma and highly perfused organs	component of a two compartment pharmacokinetic model representing plasma and highly perfused organs	Pharmacokinetics & Compartmental Modeling | Allucent		0000-0001-8345-1349	0000-0002-9795-5967		Class	one-compartment PBPK				
pkpbo:PKPBO_00302	Peripheral Compartment				component of a two compartment pharmacokinetic model representing less perfused organ like muscle and fat.	It consists of tissues where Xenoboitic distribution is slower	Two Compartment Body Model and Vd Terms (ufl.edu)		0000-0001-8345-1349	0000-0002-9795-5967		Class	one-compartment PBPK				
pkpbo:PKPBO_00303	elimination											Class	Biochemical Parameters				
pkpbo:PKPBO_00304	linear elimination				elimination following first-order kinetics.				0000-0001-8345-1349	0000-0002-9795-5967		Class	elimination				
pkpbo:PKPBO_00305	non-linear elimination				a pharmacokinetic (PK) phenomenon where the elimination of a drug from the body does not follow first-order kinetics		Goodness of fit for nonlinear model - Cross Validated (stackexchange.com)		0000-0001-8345-1349	0000-0002-9795-5967		Class	elimination				
pkpbo:PKPBO_00306	Evaluation of PBPK								0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00307	goodness of fit				a model evaluation technique used to assess how well a statistical model fits the observed data		10.1111/j.1365-2125.2010.03891.x		0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00308	Observed				exprimental data				0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00309	Predicted				predicted by the model				0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00310	visual predictive check				provides a visual comparison between observed data and model predictions				0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00311	average fold error				"a metric used to assess the accuracy of predictions made by a model. It is calculated as the average of the absolute values of the differences between the predicted and observed values, divided by the observed values"		10.1007/s10928-020-09684-2		0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00312	Residual error magnitude				the magnitude of the difference between the observed value and the predicted value in a regression analysis.		Residual Standard Deviation/Error: Guide for Beginners   QUANTIFYING HEALTH		0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00313	Mean Relative derivation				"a measure of the deviation of a set of values from their mean, expressed as a percentage"	"a measure of the deviation of a set of values from their mean, expressed as a percentage"	How to Find a Relative Average Deviation | Sciencing		0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00314	Geometric mean fold error				a measure used to compare predicted and observed values in pharmacokinetic models	a measure used to compare predicted and observed values in pharmacokinetic models	10.1002/psp4.12646		0000-0001-8345-1349	0000-0002-9795-5967		Class	Evaluation of PBPK				
pkpbo:PKPBO_00315	Sensitivty Analysis			SA	The process of investigating the role of input parameters in determining the model output. It seeks to quantify the importance of each model input parameter on the output.	Quantifying process of investigating input parameters role in determining model output	https://gsa-module.readthedocs.io/en/develop/implementation/gsa.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00316	Local Senstivity analysis			LSA	"analyzes the effect of one model parameter at a time, keeping the other parameters fixed"	"analyzes the effect of one model parameter at a time, keeping the other parameters fixed"	Sensitivity Analysis in SimBiology - MATLAB & Simulink (mathworks.com)		0000-0001-8345-1349	0000-0002-9795-5967		Class	Sensitivty Analysis				
pkpbo:PKPBO_00317	Global Sensitvity analysis			GSA	quantifies the impact of variations in model inputs on the model output. A sensitivity analysis is considered to be global when all the input factors are varied simultaneously and the sensitivity is evaluated over the entire range of each input factor.	quantifies the impact of variations in model inputs on the model output. A sensitivity analysis is considered to be global when all the input factors are varied simultaneously and the sensitivity is evaluated over the entire range of each input factor.	10.1007/978-0-387-35973-1_538		0000-0001-8345-1349	0000-0002-9795-5967		Class	Sensitivty Analysis				
pkpbo:PKPBO_00318	one at a time sensitivity analysis			OTA	"It analyzes the effect of one parameter on the cost function at a time, keeping the other parameters fixed. They explore only a small fraction of the design space, especially when there are many parameters. Also, they do not provide insight about how the interactions between parameters influence the cost function."	"It analyzes effect of one parameter on cost function at a time, keeping other parameters fixed. eg. Local sensitivity analysis"	https://www.mathworks.com/help/sldo/ug/what-is-sensitivity-analysis.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Sensitivty Analysis				
pkpbo:PKPBO_00319	Lifetsages	Aging	Biology		"Life stages in the context of the human species refer to the different phases of an individual's life, from birth to death."	"Life stages in the context of the human species refer to the different phases of an individual's life, from birth to death."			0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiological Parameters				
pkpbo:PKPBO_00320	Fetus	Preborn/Unborn baby	Mammalian development/Lifestages		"A fetus is the growth  and developmental stage of a mammal,  after the embryonic stage."	Unborn offspring in uterus representing  postembryonic stage of development until birth.	https://link.springer.com/referenceworkentry/10.1007/978-3-319-47829-6_62-1		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00321	Infants	"Newborn/
Neonate"	Mammalian development/Lifestages	Inf	"An infant is a very young child,  under the age of one year, who is in the early stages of life and development, especially in the period immediately following birth."	"An infant is a very young child, under age of one year."	https://www.cdc.gov/ncbddd/childdevelopment/positiveparenting/adolescence2.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00322	Toddlers		Mammalian development/Lifestages	Tdl	Toddlers are young children who are  between the ages of one and three years old.  (infancy to early childhood)	Young children who are  between  ages of one and three years old.  (infancy to early childhood)	https://www.cdc.gov/ncbddd/childdevelopment/positiveparenting/adolescence3.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00323	Children	youngstar	Mammalian development/Lifestages		Children are young human beings  ranging from 3-11 years.	"Children, who are in  early ages ranging from 3-11 years."	https://www.cdc.gov/ncbddd/childdevelopment/positiveparenting/adolescence4.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00324	Teenagers	"Young teen/ 
older school age"	Mammalian development/Lifestages		A human life stage that begins at eleven years of age and continues until fifteen years of age.	A human life stage that begins at eleven years of age and continues until fifteen years of age.	https://www.cdc.gov/ncbddd/childdevelopment/positiveparenting/adolescence5.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00325	Adolescent	"pubescence
teens"	Mammalian development/Lifestages		An adolescent is a young person who is in the transitional stage between Teenagers and adulthood.(Age range of 15 till 18 years)	"An adolescent, transitional stage between Teenagers and adulthood.(Age range of 15 till 18 years)"	https://www.cdc.gov/ncbddd/childdevelopment/positiveparenting/adolescence6.html		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00326	Adult	full adolescence	Mammalian development/Lifestages		A human life stage that begins at eighteen years of age and continues until thirty years of age.	A human life stage that begins at eighteen years of age and continues until thirty years of age.	http://purl.bioontology.org/ontology/BIN/BIN_00000008		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00327	Middle age	young age	Mammalian development/Lifestages		A human life stage that begins at thirty years of age and continues until forty-five years of age.	A human life stage that begins at thirty years of age and continues until forty-five years of age.	http://purl.bioontology.org/ontology/BIN/BIN_00000008		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00328	old age		Mammalian development/Lifestages		A human life stage that begins at forty-five years of age and continues until sixty years of age.	A human life stage that begins at forty-five years of age and continues until sixty years of age.	http://purl.bioontology.org/ontology/BIN/BIN_00000008		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00329	pediatric	Pediatric population	Mammalian development/Lifestages		"A human population, below fifteen years of age"	"A human population, below fifteen years of age"	http://purl.bioontology.org/ontology/SNOMEDCT/376171000221106		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00330	geriatric	geriatric population	Mammalian development/Lifestages		Geriatric refers to the medical specialty focused on providing care for the unique health needs of older adults	Geriatric refers to the medical specialty focused on providing care for the unique health needs of older adults	Geriatrics - Wikipedia		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lifetsages				
pkpbo:PKPBO_00331	Normal child	Normal young child	BMI		"A normal child, has no serious physical or mental health problems."	"A normal child, has no serious physical or mental health problems. "	http://www.gamuts.net/entity#normal_young_child		0000-0001-8345-1349	0000-0002-9795-5967		Class	Children				
pkpbo:PKPBO_00332	obese child		BMI		A Body Mass Index (BMI) greater than or equal to the 95th percentile for age and gender in children aged two years and older.	A Body Mass Index (BMI) greater than or equal to the 95th percentile for age and gender in children aged two years and older.	https://www.ncbi.nlm.nih.gov/books/NBK570626/		0000-0001-8345-1349	0000-0002-9795-5967		Class	Children				
pkpbo:PKPBO_00333	Uncertainty				"Uncertainty in Physiologically Based Pharmacokinetic (PBPK) modeling is introduced by two main sources: the underlying biology or mechanisms, and drug/chemical-related parameters"	"Uncertainty in Physiologically Based Pharmacokinetic (PBPK) modeling is introduced by two main sources: the underlying biology or mechanisms, and drug/chemical-related parameters"	10.1002/cpt.1013		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00334	Variability				Inter-individual differences  in the anatomical and physiological characteristics of humans or animal	Inter-individual differences  in anatomical and physiological characteristics 	https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=web&cd=&ved=0CDcQw7AJahcKEwjQvMPUjaCBAxUAAAAAHQAAAAAQAw&url=https%3A%2F%2Fineris.hal.science%2Fineris-00961755%2Fdocument&psig=AOvVaw3AvQT5ScYcsFkSX2UzYiCn&ust=1694437476436418&opi=89978449		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00335	Monte carlo simulation			MC	"Monte Carlo simulation is a form of uncertainty analysis that allows the propagation of uncertainty through a model, which results in an estimate of the variance in model output"	"Monte Carlo simulation is a form of uncertainty analysis that allows the propagation of uncertainty through a model, which results in an estimate of the variance in model output"	10.1289/ehp.96104858		0000-0001-8345-1349	0000-0002-9795-5967		Class	Uncertainty				
pkpbo:PKPBO_00336	Brain PBPK				Brain PBPK model build to predict the concentration of drug/chemical in different brain regions with respect to time				0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00337	Spinal CSF volume				total volume of CSF present in spine				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00338	Cranial CSF volume				total volume of CSF present in cranial				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00339	Brain mass				brain weight measured in Kg or pounds				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00340	BBB				Blood-brain-barrier				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00341	Spinal CSF flow				total CSF flowing in spinal region				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00342	Cranial CSF flow				total CSF flowing in cranial region				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00343	BCSFB				Blood-cerebrospinal fluid- barrier				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00344	vhippocampus				volume of hippocampus				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00345	vfrontalcortex				volume of frontal cortex				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00346	vcerebrum				volume of cerebrum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00347	vcerebellum				volume of cerebellum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00348	Qhippocampus				"Qhippocampus is a parameter used in PBPK modeling to describe the blood flow rate to thehippocampus, which is used to calculate the rate of drug/chemical delivery to the hippocampus. The value of Qhippocampus depends on the species of interest and is defined by the hippocampus weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00349	Qfrontalcortex				"Qfrontalcortex is a parameter used in PBPK modeling to describe the blood flow rate to the frontalcortex, which is used to calculate the rate of drug/chemical delivery to the frontalcortex. The value of Qfrontalcortex depends on the species of interest and is defined by the frontalcortex weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00350	Qcerebrum				"Qcerebrum is a parameter used in PBPK modeling to describe the blood flow rate to the cerebrum, which is used to calculate the rate of drug/chemical delivery to the cerebrum. The value of Qcerebrum depends on the species of interest and is defined by the cerebrum weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00351	Qcerebellum				"Qcerebellum is a parameter used in PBPK modeling to describe the blood flow rate to the cerebellum, which is used to calculate the rate of drug/chemical delivery to the cerebellum. The value of Qcerebellum depends on the species of interest and is defined by the cerebellum weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00352	Khippocampus:brain				ratio of drug/chemical concentration in the hippocampus tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00353	kcerebrum:brain				ratio of drug/chemical concentration in the cerebrum tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00354	kcerebellum:brain				ratio of drug/chemical concentration in the cerebellum tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00355	kfrontalcortex:brain				ratio of drug/chemical concentration in the frontal cortex tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00356	Pappcerebrum:brain				Permeability of drug/chemical in cerebrum to brain				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00357	Pappcerebellum:brain				Permeability of drug/chemical in cerebellum to brain				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00358	Papphippocampus:brain				Permeability of drug/chemical in hippocampus to brain				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00359	Pappcortex:brain				Permeability of drug/chemical in cortex to brain				0000-0001-8345-1349	0000-0002-9795-5967		Class	Brain PBPK				
pkpbo:PKPBO_00360	Pregnant PBPK				PBPK model build to predict the concentration of drug/chemical in pregnant female with time				0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00361	fetoplacental volume				"Volume can be calculated by adding the uterus weight, placenta volume, fetal volume, and amniotic fluid volume"		10.1208/s12248-013-9505-3		0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00362	vfetus				Volume of fetus				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00363	vplacenta				Volume of placenta				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00364	vamnioticfluid				Volume of amniotic fluid				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00365	vliverfetus				Volume of liver in fetus				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00366	vbrainfetus				Volume of brain in fetus				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00367	vkidneyfetus				Volume of kidney in fetus				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00368	vrestbodyfetus				Volume of rest body in fetus calculated by subtracting the body with all the organs mentioned in PBPK				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00369	placenta volume				volume of placenta				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00370	fetoplacental blood flow								0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00371	fetal cardiac output				"Fetal Cardiac output in PBPK modeling refers to the volume of blood pumped by the fetal heart per unit of time, which is used to calculate the rate of blood flow to different organs and tissues in the fetal body"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00372	Qliverfetus				"Qliverfetus is a parameter used in PBPK modeling to describe the blood flow rate to the liver fetus, which is used to calculate the rate of drug/chemical delivery to the liver in fetus. The value of Qliverfetus depends on the species of interest and is defined by the fetal liver weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00373	Qkidneyfetus				"Qkidneyfetus is a parameter used in PBPK modeling to describe the blood flow rate to the kidney fetus, which is used to calculate the rate of drug/chemical delivery to the kidney in fetus. The value of Qkidneyfetus depends on the species of interest and is defined by the fetal kidney weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00374	Qbrainfetus				"Qbrainfetus is a parameter used in PBPK modeling to describe the blood flow rate to the brain fetus, which is used to calculate the rate of drug/chemical delivery to the brain in fetus. The value of Qbrainfetus depends on the species of interest and is defined by the fetal brain weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00375	Qrestbodyfetus				"Qrestbodyfetus is a parameter used in PBPK modeling to describe the blood flow rate to the restbody fetus, which is used to calculate the rate of drug/chemical delivery to the restbody in fetus. The value of Qrestbodyfetus depends on the species of interest and is calculating by sutracting the total blood flow by the all organ considered in fetal pbpk"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00376	Gestational age				" measure of the age of a pregnancy, indicating how far along the pregnancy is. Typically measured in weeks"		Gestational age - Wikipedia		0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00377	Gestational week				" measure of the week of a pregnancy, indicating how far along the pregnancy is. "				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00378	Vmax fetus				Vmax for a particular drug/chemical in fetus				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00379	aminotic transfer coefficient				Rate at which drug/chemical transfer from materal circulation to amniotic fluid 		10.1208/s12248-021-00603-y		0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00380	Kliverfetus:plasma				ratio of compound concentration in the fetus of liver tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00381	kbrainfetus:plasma				ratio of compound concentration in the fetus of brain tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00382	kkidneyfetus:plasma				ratio of compound concentration in the fetus of kidney tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00383	krestbodyfetus:plasma				ratio of compound concentration in the fetus of restbody tissue to its concentration in the plasma				0000-0001-8345-1349	0000-0002-9795-5967		Class	Pregnant PBPK				
pkpbo:PKPBO_00384	Kidney PBPK				Kidney PBPK model is build to predict the concentration of compound in different compartments of kidney with time				0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00385	Bowmans capsule	"Capsule, Bowman's"			A double-walled epithelial capsule that is the bulbous closed proximal end of the kidney tubular system. It surrounds the cluster of convoluted capillaries of KIDNEY GLOMERULUS and is continuous with the convoluted PROXIMAL KIDNEY TUBULE.	Double-walled epithelial capsule that is bulbous closed proximal end of kidney tubular system	http://purl.bioontology.org/ontology/MESH/D050476		0000-0001-8345-1349	0000-0002-9795-5967		Class	Kidney PBPK				
pkpbo:PKPBO_00386	Filtrate				Filtrate is a role of liquid outcome of a filtration process that is commonly the mechanical or physical operation which is used for the separation of solids from fluids (liquids or gases) by interposing a medium through which only the fluid can pass	"Role of liquid outcome of filtration process, commonly mechanical or physical operation which is used for solids separation from fluids (liquids or gases) by interposing medium through which only fluid can pass"	http://purl.allotrope.org/ontologies/role#AFRL_0000228		0000-0001-8345-1349	0000-0002-9795-5967		Class	Kidney PBPK				
pkpbo:PKPBO_00387	Proximal tubule	pronephric nephron			"The proximal segment of the pronephric tubule, closest to the glomus and functioning in solute resorption and waste excretion"	"Proximal segment of pronephric tubule, closest to glomus and functioning in solute resorption and waste excretion"	http://purl.obolibrary.org/obo/XAO_0004518		0000-0001-8345-1349	0000-0002-9795-5967		Class	Kidney PBPK				
pkpbo:PKPBO_00388	loop of henle				"A highly specialized segment of the mammalian kidney tubules, that dips into the medulla"	Highly specialized segment of mammalian kidney tubules that dips into medulla	http://purl.obolibrary.org/obo/VHOG_0001270		0000-0001-8345-1349	0000-0002-9795-5967		Class	Kidney PBPK				
pkpbo:PKPBO_00389	distal tubule				"The distal segment of the pronephric tubule, functioning in water resorption, with urine passing through it into the pronephric duct."	"Distal segment of pronephric tubule, functioning in water resorption, with urine passing through it into pronephric duct"	http://purl.obolibrary.org/obo/XAO_0004519		0000-0001-8345-1349	0000-0002-9795-5967		Class	Kidney PBPK				
pkpbo:PKPBO_00390	collecting duct								0000-0001-8345-1349	0000-0002-9795-5967		Class	Kidney PBPK				
pkpbo:PKPBO_00391	bladder				"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra."	"Distensible sac-like organ, functioning as urine reservoir, collecting from kidneys and eliminating via urethra"	http://purl.obolibrary.org/obo/NCIT_C12414		0000-0001-8345-1349	0000-0002-9795-5967		Class	Kidney PBPK				
pkpbo:PKPBO_00392	lung PBPK				PBPK model built to predict the compound concnetration in lung compartment				0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00393	extrathoracic				"the area outside of the thorax, which includes the head, neck, and upper respiratory tract. In the context of PBPK modeling, extrathoracic deposition refers to the amount of inhaled drug/chemical that is deposited in the head and upper respiratory tract before reaching the lungs"		10.1007/s40262-021-01066-2		0000-0001-8345-1349	0000-0002-9795-5967		Class	lung PBPK				
pkpbo:PKPBO_00394	thoracic								0000-0001-8345-1349	0000-0002-9795-5967		Class	lung PBPK				
pkpbo:PKPBO_00395	bronchiolar								0000-0001-8345-1349	0000-0002-9795-5967		Class	lung PBPK				
pkpbo:PKPBO_00396	alveolar								0000-0001-8345-1349	0000-0002-9795-5967		Class	lung PBPK				
pkpbo:PKPBO_00397	Gut PBPK or ADAM model				PBPK model build to predict the concentration of drug/chemical in different compartments of gut.				0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00398	FQduodenum				Fraction of blood flow to duodenum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00399	FQjejunum				Fraction of blood flow to jejunum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00400	FQileum				Fraction of blood flow to ileum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00401	FQcolon				Fraction of blood flow to colon				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00402	FQcecum				Fraction of blood flow to cecum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00403	Qduodenum				"Qduodenum is a parameter used in PBPK modeling to describe the blood flow rate to the duodenum, which is used to calculate the rate of drug/chemical delivery to the duodenum. The value of Qduodenum depends on the species of interest and is defined by the duodenum weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00404	Qjejunum				"Qjejunum is a parameter used in PBPK modeling to describe the blood flow rate to the jejunum, which is used to calculate the rate of drug/chemical delivery to the jejunum. The value of Qjejunum depends on the species of interest and is defined by the jejunum weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00405	Qileum				"Qileum is a parameter used in PBPK modeling to describe the blood flow rate to the duodenum, which is used to calculate the rate of drug/chemical delivery to the ileum. The value of Qileum depends on the species of interest and is defined by the ileum weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00406	Qcolon				"Qcolon is a parameter used in PBPK modeling to describe the blood flow rate to the colon, which is used to calculate the rate of drug/chemical delivery to the colon. The value of Qcolon depends on the species of interest and is defined by the colon weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00407	Qcecum				"Qcecum is a parameter used in PBPK modeling to describe the blood flow rate to the cecum, which is used to calculate the rate of drug/chemical delivery to the cecum. The value of Qcecum depends on the species of interest and is defined by the cecum weight/volume and cardiac output"				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00408	Fduodenum				duodenum volume as a fraction of total body weight				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00409	Fjejunum				jejunum volume as a fraction of total body weight				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00410	Fileum				ileum volume as a fraction of total body weight				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00411	Fcolon				colon volume as a fraction of total body weight				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00412	Fcecum				cecum volume as a fraction of total body weight				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00413	Vduodenum				Volume of duodenum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00414	Vjejunum				Volume of jejunum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00415	Vileum				Volume of ileum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00416	Vcolon				Volume of colon				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00417	Vcecum				Volume of cecum				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00418	blilesalt effect solubilization ratio								0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00419	mean precipitation time				"mean precipitation time is often used to predict the behavior of drugs/chemical in the human body, specifically in relation to food effects and the fasted state"		10.1208/s12248-008-9079-7		0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00420	diffusion coefficient			D	The diffusion coefficient defined as the amount of a xenoboitic that diffuses across a membrane of a given unit area per unit time when the concentration gradient is unity.	"Xenoboitic amount ,i.s diffuses across a membrane of a given unit area per unit time"	"Shargel, Leon, et al. Applied Biopharmaceutics & Pharmacokinetics. 7th ed., McGraw-Hill Education, 2015. Chaper-14,page number-380"		0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00421	particle density	absolute specific gravity		?s	a measure of the mass per unit volume of the particle. It is expressed in terms of Mg m-3.	Measure of mass per unit volume of particle	http://ecoursesonline.iasri.res.in/mod/page/view.php?id=6358		0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00422	particle radius								0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00423	intestinal transit time				time required for compound to move through the intestine				0000-0001-8345-1349	0000-0002-9795-5967		Class	Gut PBPK or ADAM model				
pkpbo:PKPBO_00424	Lactational PBPK				PBPK models built to predict the drug/chemical concentration in milk during lactation		10.1002/psp4.12662		0000-0001-8345-1349	0000-0002-9795-5967		Class	Physiologically Based Pharmacokinetic Modeling				
pkpbo:PKPBO_00425	Milk:plasma ratio				Milk to plasma ratio of a particular chemical				0000-0001-8345-1349	0000-0002-9795-5967		Class	Lactational PBPK				
pkpbo:PKPBO_00426	fumilk				fraction unbound of a chemical in milk				0000-0001-8345-1349	0000-0002-9795-5967		Class	Lactational PBPK				
pkpbo:PKPBO_00427	Cmilk				concentration in milk				0000-0001-8345-1349	0000-0002-9795-5967		Class	Lactational PBPK				
pkpbo:PKPBO_00428	daily milk intake				daily milk ingested by the baby from mother				0000-0001-8345-1349	0000-0002-9795-5967		Class	Lactational PBPK				
pkpbo:PKPBO_00429	phmilk				Ph of milk				0000-0001-8345-1349	0000-0002-9795-5967		Class	Lactational PBPK				
pkpbo:PKPBO_00430	Blood-milk-barrier				physiological barrier that separates the blood and milk compartments in lactating species. 		10.1016/j.fct.2022.112848		0000-0001-8345-1349	0000-0002-9795-5967		Class	Lactational PBPK				
pkpbo:PKPBO_00431	milk:plasma partition				partition coefficient of chemical from plasma to milk				0000-0001-8345-1349	0000-0002-9795-5967		Class	Lactational PBPK				
